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3ABSTRACT
Depression is a leading cause of disability worldwide. At worst, it may lead to
frequent hospitalisation and even premature death. The risk of suicide is
particularly high among the depressed. This study assessed whether social and
economic resources protect depressed patients from psychiatric hospital
admission and premature mortality. The study also aimed to establish the role of
alcohol and the rapidly increased antidepressant treatment of depression in these
outcomes. The study used large, longitudinal register samples of the Finnish adult
population, combining information from various administrative registers.
Depression was inferred from psychiatric hospital care and antidepressant
purchases. Treatment and depression outcomes were assessed in 1-10-year
follow-ups.
The results indicate that at least in a population already in contact with the
healthcare system, antidepressant treatment and depression outcomes vary only
modestly according to social factors. However, material aspects of socioeconomic
position  such  as  a  low  income,  not  owning  a  home  and  being  unemployed
increased the risk of hospital admission for depression by 2040 per cent among
those with previous depression treatment, even after controlling for baseline
depression severity and psychiatric comorbidity, whereas education and
occupational social class were unrelated to admission risk. Having no partner and
living without co-resident children also increased the admission risk. None of the
social factors studied buffered against excess mortality among the depressed.
Educational differences in the prevalence of antidepressant use before and after
hospital care for depression were small and mostly limited to the period after
discharge. Antidepressant use immediately after discharge was slightly less
common among those with a low level of education, but educational differences
increased thereafter as antidepressant use decreased more rapidly among this
group. Differences in daily antidepressant use that met treatment guidelines were
more pronounced than those for any antidepressant use, suggesting a need for
improving treatment adequacy and adherence particularly among patients with a
low level of education.
The study established the central role of excessive alcohol consumption as a
pathway to depression mortality. Alcohol-related causes accounted for about half
of the excess mortality of depressed men and around a third of depressed women.
Improving the detection and management of substance use problems would thus
be critical for reducing depression mortality. Increased antidepressant sales do
not seem to have prevented female suicides. However, among men an increase in
the proportion of antidepressant users receiving minimally adequate treatment
reduced non-alcohol-related suicides. The results suggest that increased
adequacy of antidepressant treatment has been more central in reducing suicide
rates than the mere increase in per-capita antidepressant sales or prevalence of
antidepressant use.
4ABSTRAKTI
Masennus on yleinen mielenterveyden häiriö, joka vakavimmillaan vaatii sai-
raalahoitoa ja voi johtaa jopa ennenaikaiseen kuolemaan. Erityisesti itsemur-
han riski on masentuneilla suuri. Tämän tutkimuksen tavoitteena oli selvittää,
suojaavatko sosiaaliset ja taloudelliset resurssit, kuten korkea koulutus, kor-
keat tulot, työssäolo tai perhe, masennuspotilaita psykiatriseen sairaalahoi-
toon päätymiseltä ja ennenaikaiselta kuolemalta. Lisäksi tarkasteltiin, millai-
nen merkitys yhtäältä alkoholinkäytöllä ja toisaalta nopeasti yleistyneellä ma-
sennuslääkkeiden käytöllä on masennuksen ennusteelle. Tutkimuksessa käy-
tettiin laajoja rekisteriaineistoja, joissa masennus pääteltiin psykiatrisen sai-
raalahoidon ja masennuslääkkeiden käytön perusteella. Masentuneiden lääk-
keiden käyttöä ja ennustetta tarkasteltiin 1-10 vuoden seurannassa.
 Tutkimuksen perusteella väestöryhmien väliset erot masennuslääkehoi-
dossa sekä masennuksen ennusteessa ovat vähäisiä ainakin jo masennuksen
vuoksi hoidon piirissä olevilla. Puolison kanssa asuminen sekä materiaaliset
resurssit, kuten korkeat tulot, omistusasuminen ja työssä olo kuitenkin suoja-
sivat masennuspotilaita masennuksen vuoksi sairaalaan päätymiseltä. Sen si-
jaan korkea koulutus tai korkea ammattiasema eivät suojanneet sairaalahoi-
toon päätymiseltä. Mitkään tutkituista sosiaalisista ja taloudellisista resurs-
seista eivät suojanneet masennuspotilaita ennenaikaiselta kuolemalta. Koulu-
tusryhmien väliset erot masennuslääkkeiden käytössä ennen masennukseen
saatua sairaalahoitoa ja sen jälkeen olivat pieniä ja rajoittuivat sairaalahoidon
jälkeiseen aikaan. Lääkekäyttö oli hieman vähäisempää matalasti koulute-
tuilla heti sairaalajakson jälkeen, mutta erot kasvoivat seurannan aikana, sillä
matalasti koulutetut lopettivat lääkekäytön nopeammin. Koulutusryhmien vä-
liset erot korostuivat päivittäisessä, hoitosuositusten mukaisessa lääkekäy-
tössä. Tulosten perusteella olisi syytä kiinnittää huomiota etenkin matalasti
koulutettujen masennuspotilaiden hoidon riittävyyteen ja jatkuvuuteen.
Tutkimus osoitti, että alkoholinkäyttö on keskeinen syy masennuspotilai-
den korkeaan kuolleisuuteen: miehillä masennuspotilaiden korkeammasta
kuolleisuudesta noin puolet ja naisilla noin kolmannes johtui alkoholista.
Päihdeongelmien havaitseminen ja hoito ovatkin tutkimuksen perusteella kes-
keisessä roolissa masennuspotilaiden kuolleisuuden ehkäisyssä. Masennus-
lääkkeiden käytön yleistyminen ei näytä ehkäisseen naisten itsemurhia. Mie-
hillä hoidon keston vähimmäiskriteerit täyttävän masennuslääkehoidon yleis-
tyminen näyttäisi kuitenkin ehkäisseen sellaisia itsemurhia, joissa uhrin alko-
holipäihtymys ei ollut myötävaikuttavana tekijänä. Tulosten perusteella ma-
sennuslääkehoidon yleistyminen sinänsä ei näyttäisi ehkäisseen itsemurhia,
vaan keskeistä on ollut kestoltaan riittävän hoidon yleistyminen.
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91 INTRODUCTION
Most people experience feelings of sadness and loss of enjoyment during their
lifetime.  This  may  be  a  normal  reaction  to  negative  life  events  and  difficult
circumstances.  However,  if  these  feelings  are  strong  and  persistent,  and
significantly impair the ability to function, they may indicate the presence of
clinical depression, which is considered a psychiatric disorder. Depression is a
major public-health burden globally, accounting for around 10 per cent of life-
years lived with disability (Murray et al., 2012). It has been estimated in cross-
national studies that around five per cent of people suffer from depression at
any given time (Ferrari et al., 2013), and that an average 15 per cent of people
in high-income countries and 11 per cent in low-to-middle-income countries
suffer from depression during their lifetime (Bromet et al., 2011).
Depression is a pressing public-health issue not only because of its high
prevalence but also because of its uneven distribution across the population
and thus its contribution to social inequalities in health. Epidemiological
studies  have  consistently  reported  depression  to  be  more  common  among
people who are not married or living with a partner, and who are unemployed
(Andrade  et  al.,  2003;  Bijl  et  al.,  1998;  Bromet  et  al.,  2011;  Goodwin  et  al.,
2006;  Joutsenniemi  et  al.,  2006;  Paul  and  Moser,  2009;  Pinto-Meza  et  al.,
2013).  Many  studies  also  indicate  that  depression  is  more  common  among
those  in  low  socioeconomic  positions,  but  the  evidence  is  less  consistent
(Andrade et al., 2003; Kessler and Bromet, 2013; Lorant et al., 2003;
Markkula et al., 2015; Pinto-Meza et al., 2013; Pirkola et al., 2005). Reducing
social  inequalities  in  health  is  a  major  goal  in  public-health  policy  both  in
Finland and internationally (Sihto and Palosuo, 2013).
Social inequalities in depression are only partly determined by differences
in prevalence, however, and may also be caused by differentials in its course
and outcomes. Depression frequently has a recurring or chronic course
(Hardeveld  et  al.,  2010;  Steinert  et  al.,  2014),  and  the  risk  of  premature
mortality, suicide in particular, is high (Harris and Barraclough, 1998; Wulsin
et al., 1999). The extent to which economic and social resources protect against
the adverse outcomes of depression is not well established. In order to tackle
social inequalities in depression a better understanding is needed on whether
some social groups manage better with depression than others. The aim in this
study is to broaden current knowledge of the extent of social differentials in
depression outcomes, and of the underlying mechanisms. It therefore
examines  how  adverse  outcomes  vary  according  to  social  factors  such  as
socioecnomic position, employment status and living arrangements, and
sheds light on the role of alcohol and depression treatment in bringing about
this variation.
Existing evidence concerning social  differentials in depression outcomes
is inconsistent, some studies showing worse outcomes among people in a low
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socioeconomic position and the unmarried, whereas others report no such
differentials (Bjerkeset et al., 2008; Bracke, 1998; Cole et al., 1999; Dowrick et
al., 2011; Eaton et al., 2008; Hardeveld et al., 2010; Kessing et al., 1998; Licht-
Strunk et al., 2007; Lorant et al., 2003; Steinert et al., 2014). Few studies have
assessed social differentials in mortality among depressed people, and
differentials according to socioeconomic or living-arrangement factors have
rarely been found (Fuhrer et  al.,  1999; Hawton et  al.,  2013;  Leinonen et  al.,
2014; Schneider et al., 2001). Most of these earlier studies are based on small
samples,  however,  and may lack the statistical  power to detect  differentials.
There is thus a need for studies based on large population samples.
Reducing premature mortality among people with depression requires a
better understanding of the mechanisms behind the excess mortality. Alcohol
is  one  of  the  leading  causes  of  working-age  mortality  in  Finland  (Statistics
Finland,  2012),  and is  a  major contributor to socioeconomic differentials  in
mortality (Martikainen et al., 2014; Tarkiainen et al., 2011). Although it has
been  suggested  that  excessive  alcohol  consumption  is  a  notable  pathway
between  depression  and  mortality  (Wulsin  et  al.,  1999),  there  is  as  yet  no
evidence concerning the contribution of alcohol-related causes to the excess
mortality of depression.
Another major cause of death among the depressed is suicide.
Psychological autopsy studies have shown 30–90% of suicides to be linked to
depression  (Lönnqvist,  2000),  and  better  detection  and  treatment  of
depression and other mental health problems are key elements in suicide-
prevention  strategies  in  Finland  and  elsewhere  (Beskow et  al.,  1999;  World
Health Organization, 2014). The most common treatment alternative for
depression is antidepressant medication, which has shown a moderate effect
in reducing depressive symptoms (Melander et al., 2008; Turner et al., 2008).
However, its effectiveness in suicide prevention is still under debate. The rapid
increase in antidepressant treatment since the emergence of new types of
antidepressants  at  the  end  of  the  1980s  has  coincided  with  a  decrease  in
suicide  mortality  in  many  countries,  including  Finland  (Baldessarini  et  al.,
2007). Some researchers have interpreted this as a medical breakthrough in
suicide prevention (Isacsson 2000, Isacsson et al. 2010), whereas others are
more  sceptical  (Isacsson  et  al.,  2010;  Safer  and  Zito,  2007).  Despite  the
abundance  of  research  on  the  matter,  little  is  known  about  the  effect  of
increased antidepressant sales on alcohol-related suicides, a substantial
subtype particularly among men and those in a low socioeconomic position
(Mäki and Martikainen, 2009, 2008). Furthermore, few studies have assessed
the impact of increased antidepressant treatment across population subgroups
based on gender, socioeconomic position or living arrangements. Given that
population subgroups may differ in terms of access to treatment as well as the
propensity to seek and adhere to it, it is possible that the increase in treatment
has not benefitted all groups equally.
Differential access and adherence to effective depression treatment may be
one  pathway  through  which  social  factors  affect  depression  outcomes.
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Inadequate treatment for mental-health problems and its unequal distribution
constitute a common concern among public-health professionals, given that
treatment  seems  to  be  received  disproportionately  by  those  with  more
socioeconomic  resources  (Bijl  et  al.,  2003;  The  WHO World  Mental  Health
Survey Consortium, 2004). Whether this applies to antidepressant treatment
of depression as well is not clear based on current evidence (Andersen et al.,
2009; Butterworth et al., 2013; Colman et al., 2008; Hämäläinen et al., 2009;
Hansen et al., 2004a; Kivimäki et al., 2007; Mauramo et al., 2012; Roer et al.,
2010). Studies explicitly assessing the need for treatment are scarce, and thus
it is difficult to determine whether any observed differences in treatment
reflect  differences  in  need  or  in  access.  There  is  also  a  lack  of  longitudinal
studies comparing long-term trajectories of antidepressant use between social
groups that would be able to evaluate differences in both access and adherence
to treatment. There is a clear need to enhance understanding of the extent to
which social differences in treatment are driven by unequal access or
differential continuity, and consequently of the types of intervention that
would be most effective in decreasing social differentials in treatment and its
outcomes.
The  objective  of  this  study  is  to  enhance  knowledge  about  social
inequalities in depression through the assessment of social differentials in
depression  outcomes  such  as  psychiatric  hospital  care  and  premature
mortality. The investigation also covers educational differentials in
longitudinal trajectories of antidepressant use, which constitute a potential
pathway for bringing about social differentials in depression outcomes. A
further aim is to quantify the contribution of alcohol-related deaths to
depression mortality, and to establish the extent to which the increased use of
antidepressants has prevented alcohol-related and non-alcohol-related
suicides  across  social  groups.  The  study  is  based  on  large,  nationally
representative  population  register  samples  from  Finland,  with  linkages  to
routinely collected administrative data on socioeconomic and living-
arrangement factors, hospital care, medication use and mortality. These
register-based data are unique in that they allow the longitudinal assessment
of  antidepressant  use,  and  even  of  rare  depression  outcomes  such  as
psychiatric admission and suicide in large population samples without
selective  attrition  or  loss  to  follow-up.  These  are  problems,  which  may
seriously  compromise  the  quality  of  survey-based  or  clinical  data  that  are
commonly used in psychiatric epidemiology (Fischer et al., 2001).
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2 THE CONCEPTUAL FRAMEWORK OF
THE STUDY
2.1 DEPRESSION: DEFINITION AND EPIDEMIOLOGY
A  sad  mood  and  a  lack  of  enjoyment  are  part  of  human  life  and  normal
emotional  reactions  to  loss  and  other  difficult  circumstances.  Sadness  may
even serve useful functions, such as prompting sympathy and help from others
or motivating the individual  to recover what has been lost  (Wolpert,  2008).
Overwhelming sadness that exceeds the limits of normal reactions, however,
has been acknowledged under different names throughout written history
(Eaton, 2001). In current psychiatric nosology it is called depression. Where
the limit should be set between normal sadness and depression as a psychiatric
disorder  is  a  matter  of  controversy,  even  within  psychiatry  (Horwitz  and
Wakefield, 2007).
According to the two major psychiatric classification systems in use today,
the International Statistical Classification of Diseases Tenth Revision (ICD-10)
produced by the World Health Organization, and the two most recent versions
of the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV and
DSM-5)  produced  by  the  American  Psychiatric  Association,  the  formal
diagnosis of depression is purely symptom-based. The different depressive
disorders are diagnosed according to the number, type, severity and duration
of the presented symptoms (American Psychiatric Association, 2013, 1994;
World  Health  Organization,  1993,  1992).  Depression  is  thus  seen  as  a
heterogeneous syndrome (Depression: Current Care Guidelines, 2014; NICE,
2009)  rather  than  a  uniform  disorder  with  a  clear  aetiology  (Carney  and
Freedland, 2000).
The diagnosis of a major depressive disorder in according to DSM-IV and
DSM-5 (referred to as depressive disorder in ICD-10 (World Health
Organization, 1993, 1992)) requires the presence of a persistent depressive
mood or loss of interest and enjoyment for a period of at least two weeks, as
well as at least four of the following symptoms: loss of energy, reduced self-
esteem, unreasonable feelings of guilt and unworthiness, suicidal ideation or
behaviour, reduced concentration, psychomotor agitation or retardation, sleep
disturbance,  and  changes  in  appetite.  Furthermore,  the  symptoms  have  to
cause clinically significant distress or impairment in functioning (American
Psychiatric Association, 2013, 1994). Major depression is further divided into
mild,  moderate  and  severe  according  to  the  number  of  symptoms  and  the
extent of impairment. In its most severe form it may include psychotic features
such as delusions and hallucinations. Major depressive disorder is diagnosed
only  among  individuals  with  no  history  of  manic,  hypomanic  or  mixed
episodes, which are indicative of bipolar affective disorders. The term unipolar
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depression  is  often  used  so  as  to  emphasise  the  distinction  from  bipolar
disorders.
Other unipolar depressive disorders include postnatal depression and
dysthymia. Postnatal depression is a major depressive episode occurring
within four weeks of delivery. A persistent affective disorder lasting for years
with constantly recurring depressed mood and other depressive symptoms,
but no or few episodes meeting the criteria for a major depressive episode, is
called  dysthymia  (in  ICD-10,  DSM-IV)  or  persistent  depressive  disorder  (in
DSM-5) depending on the classification system (American Psychiatric
Association, 2013, 1994; World Health Organization, 1993, 1992). Depressive
symptoms  not  meeting  the  full  criteria  for  a  major  depressive  disorder  or
dysthymia are often referred to as “subthreshold” or “subclinical” depression
(Judd  et  al.,  2002).  These  milder  symptoms  have  been  shown  to  cause
considerable impairment and to have similar outcomes to clinical depression
(Cuijpers  and  Smit,  2002;  Judd  et  al.,  2002;  Solomon  et  al.,  2001).  It  is  a
matter of debate whether there is continuity between subclinical depressive
symptoms and clinical depression, or whether clinical depression meeting
diagnostic criteria is a qualitatively distinct and categorical entity (Klein et al.,
2007; Solomon et al., 2001).
The way depression and depressive disorders in general are conceptualised
has  implications  for  how  they  should  be  measured  in  research.  If  one  sees
depression  as  a  categorical  entity—a  disorder  with  clear  limits  defining  a
disordered mood—then a diagnostic schedule is a proper measurement. If one
thinks of it as continuous, with increasing severity as symptoms increase,
however, then an inventory or a rating scale may be more suitable (Dew et al.,
2006). Diagnostic schedules such as the commonly used Composite
International Diagnostic Interview (CIDI) distinguish depressive disorders
qualitatively  from  each  other  and  from  non-disordered  mood  based  on
diagnostic criteria used in current psychiatric classification systems (DSM or
ICD). Inventories evaluate the number and severity of depressive symptoms
on a continuous scale, and are thus more sensitive than diagnostic schedules
to changes in symptomatology across measurements. However, cut-off points
are often used with inventories as well to indicate “caseness”. The most widely
used inventories include the Beck Depression Inventory (BDI) and the
Hamilton Rating Scale for Depression (HAM-D) for assessing depressive
symptoms, and the General Health Questionnaire (GHQ) for more general
psychological distress (Dew et al., 2006). As discussed below, the prevalence,
correlates,  course  and  outcomes  of  depression  vary  according  to  how  it  is
conceptualised and measured.
In this study depression is empirically measured using information from
healthcare registers, and depression is used as a broad term ranging from
hospital-treated severe depressive disorders with psychotic features to
subthreshold  depression  treated  with  antidepressants.  Thus  the  concept  of
depression used in this study is theoretically closer to the notion of depression
as a continuous rather than a categorical phenomenon. When the reference is
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to previous studies the term depression is used for both clinically assessed
depression  and  depressive  symptoms  measured  on  rating  scales,  and  the
measurements used are specified when relevant.
Depressive  disorders  are  rather  common  in  the  general  population,
although prevalence estimates across countries and studies vary considerably
(Andrade  et  al.,  2003;  Weissman  et  al.,  1996).  Community  epidemiological
surveys using the World Health Organization CIDI interview corresponding to
the DSM-IV diagnostic criteria for a major depressive episode have indicated
a mean 12-month prevalence of 5.5 per cent and a mean lifetime prevalence of
14.6  per  cent  across  10  high-income  countries,  and  5.9  and  11.1  per  cent,
respectively across eight low-to-middle-income countries (Bromet et al.,
2011). The 12-month prevalence of CIDI-measured major depression in the
Finnish general population in 2000–2001 was 4.9 per cent, and the prevalence
of any depressive disorder (including dysthymia) was 6.5 per cent (Pirkola et
al.,  2005).  Recent evidence (2011)  from Finland suggests  an increase in the
prevalence of major depressive disorder to 7.4 per cent, and of any depressive
disorder to 9.6 per cent  (Markkula et al., 2015), although a dramatic decrease
in response rate between the studies hinders reliable comparison. A
universally  increasing  trend  in  depression  has  been  suggested,  but  the
evidence  remains  inconsistent  (de  Graaf  et  al.,  2012;  Goodwin  et  al.,  2006;
Hidaka, 2012).
The reasons why some people develop depressive disorders and others do
not are not well known. Commonly acknowledged risk factors for depression
include female gender, a family history of depression, adverse childhood
experiences  such  as  neglect  or  abuse,  and  stressful  life  events  such  as
bereavement, divorce or job loss (Goodwin et al., 2006; Kendler et al., 2000,
1999). However, genetic, neurobiological and psychosocial factors have been
found to affect vulnerability to stressors in developing depression (Kendler et
al., 1995; Southwick et al., 2005). Individuals with no genetic disposition to
depression, or with strong social support, may thus be more resilient and less
likely to become depressed even when exposed to stress and negative life-
events (Southwick et al., 2005). The causal mechanisms linking the observed
risk factors with depression are thus likely to be complex and interrelated.
Comorbidity, in other words the co-occurrence of other mental disorders
such  as  anxiety  disorders  and  substance  use  disorders  as  well  as  various
physical illnesses, is common in depression (Horwath et al., 2002; Richards
and  O’Hara,  2014;  Swendsen  and  Merikangas,  2000),  and  several
mechanisms for this have been suggested. Depression may share a common
aetiology  and  risk  factors  with  the  comorbid  disorders  (Swendsen  and
Merikangas,  2000).  Pre-existing mental  and physical  disorders may also be
risk factors for depression onset: depression may be a psychological or
physiological reaction to an illness, for example (Wulsin et al., 1999). Finally,
depression may increase the risk of other psychiatric and physical disorders
via biological or behavioural pathways. Biological dysregulation, such as of the
autonomous nervous system and neuroendocrine functions, have been
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observed in depression, and they increase the risk of various somatic illnesses
such as diabetes mellitus and cardiovascular disease (Cuijpers et  al.,  2014c;
Cuijpers and Schoevers, 2004). Excessive alcohol consumption, smoking and
a  lack  of  exercise,  which  are  known  risk  factors  for  many  psychiatric  and
physical disorders, are also common in depression (Cuijpers and Schoevers,
2004; Swendsen and Merikangas, 2000). Specifically with regard to
psychiatric  comorbidity,  it  has  been  questioned  whether  the  disorders  are
comorbid in the true sense, meaning a co-occurrence of two essentially
separate disorder entities, or whether the comorbidity is in fact an artefact of
the current psychiatric classification system that splits mental disorders into
ever smaller subdiagnoses (Bebbington et al., 2000; Eaton, 2001).
2.2 OUTCOMES OF DEPRESSION
Depression tends to have a chronic or recurrent course, although evidence on
its course and outcomes seems to be strongly dependent on the study setting
(K. M. Holma et al., 2008). It has been found in studies of specialised mental
health care that only 15 per cent of depressive patients have no recurrence after
15 years (Hardeveld et al., 2010). However, stable recovery seems more
common  in  the  context  of  community  and  primary  care  (Hardeveld  et  al.,
2010; Steinert et al., 2014), probably because patients present with less severe
depression in these settings. According to a recent review of prospective
studies focused on community and primary care,  around 35–60 per cent of
people with depression had no recurrence in follow-ups ranging from three to
49  years  (Steinert  et  al.,  2014).  About  10–20 per  cent  of  the  patients  had  a
chronic course with no major improvement during follow-up, and the rest (an
average  of  39% across  the  studies)  had  a  recurring  course  with  at  least  two
episodes during follow-up.
Depression sometimes becomes so serious that extensive and recurrent
hospital care is needed. At worst, depression may even lead to premature death
(Wulsin  et  al.,  1999).  There  are  also  various  potentially  adverse  social
outcomes such as marital disruption, work disability and exclusion from the
labour  market  (Bulloch  et  al.,  2009;  Kessler  et  al.,  1998;  Luo  et  al.,  2010;
Riihimäki et al., 2014). However, such social outcomes are beyond the scope
of this study.
2.2.1 PSYCHIATRIC HOSPITAL CARE
Admission to psychiatric hospital care is used in this study as an indicator of a
negative course of depression. Being referred to a psychiatric hospital on the
grounds  of  depression  is  often  related  to  patient  suicidality  (Doerfler  et  al.,
2010) and the psychotic features of depression (Vuorilehto et al., 2007), and
thus reflects a severe deterioration in mental health. As an individual-level
experience  psychiatric  admission  could  be  considered  one  of  the  most
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distressing outcomes of a mental-health problem, generating feelings of fear,
anger  and  loss  of  self-esteem,  particularly  if  admission  is  involuntary
(Morrison  et  al.,  1999).  Costly  and  intensive  inpatient  care  is  also  an
undesirable and adverse outcome of depression from the perspective of the
healthcare system, and is sometimes even seen as the failure of previous
treatment attempts (Lyons et al., 1997). Although hospital care may be part of
a long-term treatment plan for depressive patients, it is uncommon in Finland
where the psychiatric care system focuses on outpatient services. In 2013 only
around five  per  cent  of  psychiatric  inpatients  had  repeated  hospital  care  by
pre-arrangement (Rainio and Räty, 2015).
2.2.2 MORTALITY
Another adverse outcome of depression assessed in this study is premature
death. Reviews and meta-analyses of depression mortality suggest an excess
in  all-cause  mortality  of  about  20–170  per  cent  compared  with  the  general
population (Cuijpers and Smit, 2002; Harris and Barraclough, 1998; Schulz et
al., 2002; Wulsin et al., 1999), the excess being evident in psychiatric inpatient
as  well  as  community  samples  (Cuijpers  and  Smit,  2002;  Harris  and
Barraclough,  1998;  Schulz  et  al.,  2002;  Wulsin  et  al.,  1999).  However,  the
excess seems to be larger among inpatients, suggesting that depression
severity  increases  the  risk  of  death  (Wulsin  et  al.,  1999).  Correspondingly,
according to a recent meta-analysis, major depression carried a somewhat
larger excess risk of death (60%) than sub-threshold depressive symptoms
(30%), although the difference was not statistically significant (Cuijpers et al.,
2013b).
The  causal  mechanisms  producing  the  excess  mortality  are  not  well
established, although some evidence is provided by studies assessing causes of
death. A cause of death that is causally linked to depression is suicide. Suicidal
thoughts  are  often  present  as  symptoms  of  depression,  and  according  to
psychological autopsy studies (based on posthumously gathered information
from  family  and  friends,  medical  records  and  police  reports,  for  example),
around 30–90 per cent of suicides are preceded by depression (Lönnqvist,
2000). However, suicide is a rare event, even among depressed individuals:
the lifetime prevalence of completed suicide among people with depression
ranges from around 0.5 per cent in community samples (Kuo and Gallo, 2001)
to  around  nine  per  cent  among  the  highest  risk  group,  namely  depressed
patients previously hospitalised on the grounds of  suicidality  (Bostwick and
Pankratz, 2000). Thus suicide can only explain a small part of overall excess
mortality (Cuijpers and Schoevers, 2004), particularly in the case of less severe
forms of depression. Elevated levels of other accidental and violent causes of
death (often called unnatural or external causes) have also been found among
the  depressed,  particularly  among  individuals  with  a  history  of  psychiatric
inpatient treatment (Harris and Barraclough, 1998; Hiroeh et al., 2001; Ösby
et al., 2001), indicating the significance of behavioural pathways in inducing
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depression mortality. However, evidence of increased external-cause
mortality from population samples is more scarce and inconsistent, probably
due to the low numbers of external-cause deaths observed in survey-based
studies (Joukamaa et al., 2001; Markkula et al., 2012; Mykletun et al., 2007).
An  extensive  body  of  literature  reports  higher  mortality  from
cardiovascular disease among the depressed (Wulsin et al., 1999). Depression
has been found to increase both the incidence (Steptoe,  2007) and the case
fatality  of  heart  diseases  (Barth  et  al.,  2004;  Lett  et  al.,  2007).  Given  that
cardiovascular disease is the leading cause of death worldwide (World Health
Organization,  2011),  it  is  also  likely  to  account  for  a  large  proportion  of
depression mortality. Both biological and behavioural pathways have been
suggested to explain the excess mortality from cardiovascular and other
diseases among the depressed (Cuijpers et al., 2014c; Cuijpers and Schoevers,
2004; Wulsin et  al.,  1999).  Depression may be a biological  or  psychological
reaction to a pre-existing somatic disorder that increases the risk of death on
the  one  hand  (Wulsin  et  al.,  1999),  but  on  the  other  hand  biological
dysregulations related to depression may increase the risk for various somatic
illnesses (Cuijpers et al., 2014c; Cuijpers and Schoevers, 2004). Suggested
behavioural pathways include less treatment-seeking and poorer adherence to
treatment for somatic disorders when depressed, as well as detrimental health
behaviours  such  as  excessive  alcohol  consumption,  smoking  and  a  lack  of
physical  exercise  (Cuijpers  and  Schoevers,  2004).  In  particular,  it  has  been
argued  that  excessive  alcohol  consumption  is  one  of  the  major  pathways
inducing depression mortality (Wulsin et al., 1999). Given that alcohol-related
deaths are a leading cause of working-age mortality in Finland (Statistics
Finland, 2012), their contribution to premature mortality among the
depressed is likely to be substantial.
2.3 DETERMINANTS OF DEPRESSION OUTCOMES
2.3.1 SOCIAL FACTORS
The  social  determinants  of  depression  outcomes  are  viewed  in  this  study
within  the  wider  framework  of  social  inequalities  in  health  (Berkman  and
Kawachi, 2000; Marmot and Wilkinson, 2006; Townsend and Davidson,
1988). Research on health inequalities focuses on differences in health across
population  subgroups  defined  by  socioeconomic  factors  such  as  education,
occupation, income, wealth, home ownership, area deprivation and
employment (Elo, 2009; Krieger et al., 1997; Lynch and Kaplan, 2000). These
are all aspects of the wider concept of socioeconomic position, which refers to
the  position  of  the  individual  in  the  social  hierarchy.  One  of  the  most
consistent findings in epidemiology is that a low socioeconomic position is
related to worse health according to most measures of morbidity and mortality
across time and geographical regions (Krieger et al., 1997; Lynch and Kaplan,
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2000; Mackenbach, 2012). The different aspects of socioeconomic position are
not interchangeable, however, and may affect health through different
pathways (Lahelma et al., 2004).
Education is acquired early in life, and to a large extent determines future
occupation and income. It provides people with skills and knowledge that may
help  in  avoiding  behaviours  and  lifestyles  that  are  detrimental  to  health.
Occupation, on the other hand, defines one’s position in the social hierarchy,
and also determines work-related physical  and psychosocial  exposures.  The
more material aspects of socioeconomic position such as income and wealth
may protect against stress related to financial insecurity, and facilitate health-
enhancing behaviours and access to healthcare (Herd et al., 2007; Lahelma et
al., 2004). Home ownership is the most common form of wealth (Brandolini
et al., 2008) and reflects material well-being accumulated over the lifespan
and across generations. Employment status has also be viewed as one aspect
of socioeconomic position (Lynch and Kaplan, 2000). Becoming unemployed
may  lead  to  adverse  health  effects  via  increased  psychosocial  stress,  loss  of
social networks, and a deterioration in material circumstances (Martikainen
and Valkonen, 1996).
The wider concept of social determinants of health (Marmot et al., 2008;
Marmot  and  Wilkinson,  2006)  also  encompasses  social  factors  other  than
socioeconomic position that may influence health, such as marital status and
living arrangements. The better health of married compared to nonmarried
people is a well-established epidemiological finding (Hu and Goldman, 1990;
Koskinen  et  al.,  2007;  Martikainen  et  al.,  2005),  and  research  increasingly
shows that people living in non-marital partnerships have better health than
those living alone or with someone other than a partner (Carr and Springer,
2010; Joutsenniemi et  al.,  2006; Koskinen et  al.,  2007).  Close relationships
are thought to be beneficial to health in providing emotional, social, economic
and instrumental support (Carr and Springer, 2010) as well as social control
(Umberson, 1992), and may enhance health-promoting behaviour (Lynch and
Kaplan, 2000). Living arrangements and marital status also reflect a history
(or lack) of stressful life events such as divorce and bereavement that may be
detrimental to health.
Various  theories  have  been  put  forward  to  explain  social  differentials  in
health (Carr and Springer, 2010; Mackenbach, 2012). In general, health
inequalities are perceived to result from an unequal distribution of health-
damaging exposures and health-protective resources across population
subgroups (Lynch and Kaplan, 2000). The various theories differ in terms of
which exposures (e.g., material, psychosocial or behavioural) and resources
(e.g.,  financial,  cultural,  psychosocial  or  cognitive)  are  considered  the  most
relevant  and  in  what  is  assumed  about  the  causal  ordering  of  social
circumstances and health (Mackenbach, 2012). Causal explanations
emphasise the effect of social circumstances on health, whereas explanations
based on selection suggest that people are sorted into socioeconomic groups
or living arrangements based on their health (‘direct selection’), or on health
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determinants such as personal characteristics and health behaviours (‘indirect
selection’).
With regard to depression, much of the research on social inequalities has
focused  on  differentials  in  prevalence  or  incidence  (Lorant  et  al.,  2003).
Overall, evidence indicating social differentials in depression is less consistent
than in the case of physical illness, and seems to depend on how depression is
conceptualised and measured. Studies comparing different measures of
depression and depressive symptoms report more pronounced differentials
between socioeconomic and living-arrangement groups for more severe
measures of  depression,  and a less steep or non-existent social  gradient for
more common depressive symptoms or psychological distress (Andersen et al.,
2009; Joutsenniemi et al., 2006; Kosidou et al., 2011a; Lorant et al., 2003).
Moreover and in contrast to evidence on physical illness, depression seems to
be  more  strongly  related  to  the  material  aspects  of  socioeconomic  position
such as income and past or current financial difficulties, whereas differentials
according to education and occupational social class often turn out to be small
or  non-existent:  this  is  the  case  for  less  severe  forms  of  depression  and
psychological distress in particular (Andersen et al., 2009; Fryers et al., 2003;
Kessler et al., 1997; Kosidou et al., 2011b; Laaksonen et al., 2007; Lorant et al.,
2003; Markkula et al., 2015; Pirkola et al., 2005).
Although  these  observed  associations  may  be  attributable  in  part  to  the
selection of depressed individuals into low socioeconomic positions and to
being unpartnered, exposure to stressful life-events appears to have a causal
effect on depression onset (Kendler et al., 2000, 1999). Given the evidence that
both chronic stress and acute stressful life-events are more common among
those  with  a  low  socioeconomic  position  (Lantz  et  al.,  2005;  Taylor  et  al.,
1997),  social  differentials  in  depression  onset  could  be  causally  induced  via
stress exposure. However, the social factors that appear to predict depression
onset  do  not  necessarily  predict  the  outcomes.  Efforts  to  reduce  social
inequalities in depression would therefore benefit from a better understanding
of the social processes operating at different stages of the illness (Herd et al.,
2007).
A specific theory focusing on the differential effects of social exposures at
different  stages  of  depression  is  the  kindling  hypothesis  of  mood  disorders
(Post, 1992). According to the hypothesis, exposure to major stressful life-
events plays a stronger role in the aetiology of first-onset depression than in
subsequent episodes because depressive episodes sensitise the individual to
stress so that ever smaller stress exposures may eventually inflict subsequent
episodes (Kendler et al., 2000; Monroe and Harkness, 2005; Post, 1992). On
the basis of the kindling hypothesis one would expect the course of depression
to be only weakly related to social exposures, and thus that social factors would
have little effect in determining depression outcomes.
Another specific theoretical approach to social differentials in depression
outcomes  is  the  buffering  hypothesis  (Fuhrer  et  al.,  1999).  It  was  originally
posited  to  explain  how  social  support  and  other  resources  may  modify  the
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effects  of  acute  or  chronic  stressors  on  health  (Cohen  and  Wills,  1985;
Stansfeld, 2006) but has also been used in research on depression outcomes
to test whether social support buffers against the excess mortality of
depression (Fuhrer et al., 1999). Other social and economic resources such as
a  high  level  of  education,  a  high  income  and  being  in  employment  could
similarly buffer against the excess mortality through better coping skills or
better access to treatment, for example.
The differential receipt of and adherence to effective depression treatment
is a specific pathway potentially bringing about social differentials in
depression outcomes. Treatment may be more affordable to those with more
financial  resources,  for  example,  and social  control  exerted by a co-resident
partner may enhance treatment adherence (Umberson, 1992). Differentials in
seeking treatment and in the interaction between patient and healthcare
provider  may  also  produce  social  differentials  in  the  receipt  of  appropriate
treatment for depression (Butterworth et al., 2013; Comino et al., 2000). New
treatment regimens and health interventions may also be more readily
adopted by people in higher socioeconomic positions, despite less treatment
need,  as  suggested  in  the  diffusion  of  innovations  theory  and  the  inverse-
equity hypothesis (Mackenbach, 2012; Victora et al., 2000).
2.3.2 TREATMENT
The main treatment alternatives for depression include psychotherapy,
antidepressants and—in the case of severe and psychotic depression—
electroconvulsive therapy (ECT) (American Psychiatric Association, 2010;
Depression: Current Care Guidelines, 2014; NICE, 2009). The guidelines
recommend treatment in three phases: acute, continuation and maintenance.
The  target  in  the  acute  phase  is  remission,  in  other  words  the  partial  or
preferably full relief of depressive symptoms. The phase lasts until remission
is achieved, usually for between six and eight weeks. The next phase,
continuation treatment, should last for between four and nine months after
remission  so  as  to  avoid  relapse,  in  other  words  the  return  of  depressive
symptoms. Antidepressant treatment should continue on the same dosage
level that was effective in the acute phase. After this, long-term maintenance
treatment may be called for to avoid recurrence among patients with a history
of recurring moderate to severe depression (American Psychiatric Association,
2010; Depression: Current Care Guidelines, 2014; NICE, 2009).
Meta-analyses of randomised, controlled trials have shown psychotherapy,
antidepressants and ECT to be effective in the acute phase of treatment
(Cuijpers et al., 2014a, 2008; Melander et al., 2008; Turner et al., 2008; UK
ECT  Review  Group,  2003),  although  the  effects  of  psychotherapy  and
antidepressants compared to placebos are only small to moderate (Cuijpers et
al., 2014a; Undurraga and Baldessarini, 2012). Antidepressants and
psychotherapy have proved to be equally effective in the treatment of mild to
moderate depression (Cuijpers et al., 2014b, 2013a, 2008), and a recent meta-
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analysis suggests a combination of the two may be twice as effective as either
one in isolation (Cuijpers et al., 2014b).
Antidepressant treatment in the continuation and maintenance phases has
also  been  found  to  effectively  reduce  the  risk  of  relapse  and  recurrence  in
meta-analyses of randomised controlled trials among patients who achieved
remission in acute-phase antidepressant treatment (Geddes et al., 2003;
Williams et al., 2009). Conversely, observational community studies assessing
long-term outcomes of depression such as recovery, chronicity and recurrence
report no significant associations between antidepressant or other treatments
and outcomes (Steinert et al., 2014). There may be at least two reasons for this
discrepancy. Observational studies may underestimate the positive effect of
treatment if being treated is correlated with the initial severity, chronicity and
comorbidity of the depression, all of which are strong predictors of an adverse
course  (Hardeveld  et  al.,  2010;  Steinert  et  al.,  2014).  On  the  other  hand,
continuation trials may overestimate the positive long-term effect of treatment
because they only include patients who responded positively during the acute
phase. In sum, continuation and maintenance antidepressant treatment
seems to prevent relapse among patients who benefitted from it in the acute
phase, whereas evidence concerning the benefits of continued antidepressant
use across all patients remains unclear.
Given that the available treatment options show at least a small-to-
moderate  effect  in  the  acute  phase  of  symptom  reduction,  as  well  as  in
preventing  recurrence,  a  potential  factor  affecting  outcomes  is  the  lack  of
adequate treatment. Population studies from Finland and elsewhere have
shown that only around 30–60 per cent of individuals meeting the diagnostic
criteria  for  major  depression  receive  any  treatment  (Bijl  and  Ravelli,  2000;
Hämäläinen et al., 2009, 2004; Kessler et al., 1999; Spijker et al., 2001a; Wang
et al., 2005). This implies that the detection and treatment of first-onset
episodes in the general population may be delayed and inadequate.
Furthermore, there is evidence to suggest that the degree to which depressed
patients follow the treatment as recommended—referred to as patient
compliance  or  adherence  (Mitchell  and  Selmes,  2007)—is  low (Lingam and
Scott,  2002).  It  was  found  in  a  Finnish  study  on  psychiatric  inpatient  and
outpatient care that although almost 90 per cent of the depressed patients
received acute-phase antidepressant treatment, early discontinuatiation was
common and only about a quarter of them completed a continuation phase of
at least four months (Melartin et al., 2005). The most common self-reported
reason  given  for  discontinuation  was  the  patient’s  autonomous  decision,
possibly reflecting a willingness to cope without medication  (Melartin et al.,
2005). Less common reasons included side-effects, poor response and
subjective recovery. It has also been reported that maintenance treatment is
of inadequate duration in Finland (I. A. Holma et al., 2008).
Depression seems to be particularly suboptimally treated among patients
with comorbid substance use disorders (SUD) (Blanco et al., 2012; ten Have
et al., 2004), despite the fact that antidepressant treatment has proved
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effective for both of the comorbid disorders, in particular when combined with
psychological  treatment  (Davis  et  al.,  2010;  Nunes  and  Levin,  2004).
Treatment for depression in Finland has also been found to be suboptimal
among suicidal patients (Suominen et al., 1998).
While unmet need for treatment is a common problem, the majority of all
mental-health treatment goes to mild and minor cases (Bijl et al., 2003; The
WHO World Mental Health Survey Consortium, 2004). Furthermore,
medicalization, in other words the process of defining an ever widening range
of behaviours as medical problems (Conrad, 1992; Eaton, 2001), may lead to
the over-treatment of normal emotional responses to adverse social
circumstances,  such  as  unemployment  or  bereavement  (Buffel  et  al.,  2015;
Wakefield, 2013). One concern is that this process may be at least partly driven
by aggressive marketing by the pharmaceutical industry, which has profited
from increases in the prescribing of psychotropic medication (Eaton, 2001).
Antidepressant sales have risen dramatically worldwide since the end of the
1980s when a new group of antidepressants, selective serotonin reuptake
inhibitors (SSRI) was introduced, gradually followed by other new-generation
antidepressants (Baldessarini et al., 2007). Both SSRIs and these other new-
generation antidepressants are better tolerated and less toxic in overdose than
the older tricyclic antidepressants that have been in use since the 1950s, and
this has led to easier prescribing and monitoring in primary care (Reseland et
al.,  2006).  The  consumption  of  antidepressants  in  Finland  increased  from
around seven  daily  doses  per  1,000 inhabitants  in  1990 to  over  70  in  2010
(National Agency for Medicines and Social Insurance Institution, 2012), and
the role of general practitioners as prescribers has increased markedly (Sihvo
et al., 2010). It is not known how this increased use has been allocated with
respect to treatment need. Around a quarter of Finnish antidepressant users
studied in 2000 had no known psychiatric morbidity (Sihvo et al., 2008).
2.3.3 THE ROLE OF ANTIDEPRESSANTS IN SUICIDE PREVENTION
A particular question regarding the effects of treatment on depression
outcomes concerns suicide prevention. Given that depression is one of the
main risk factors for suicide, its better detection and treatment could well have
a preventive effect. Antidepressants and interpersonal psychotherapy have
been  found  to  reduce  mild  suicidal  ideation  more  than  placebos  among
depressed patients, largely as a consequence of their more general effects on
depression (Weitz et al., 2014). However, treatment trials, the gold standard
for proving medication effects, have been unable to show positive effects on
completed  suicide–largely  for  methodological  reasons  such  as  a  lack  of
statistical power and short follow-ups (Gunnell et al., 2005).
Several countries, including Finland, have witnessed a marked decline in
suicide mortality rates since the expansion in the use of new-generation
antidepressants (Baldessarini et al., 2007; Bramness et al., 2007; Reseland et
al., 2006). It would therefore be plausible to assume that the increased level of
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treatment for depression could have led to a decline in the rates of completed
suicide. This could be attributable to specific treatment effects, but also to
nonspecific mechanisms such as a growing awareness of depression as well as
increased treatment optimism among physicians and patients following the
emergence of the new treatment alternatives. Changes in treatment adequacy
in  particular  could  be  a  mechanism  affecting  suicide  rates,  the  duration  of
antidepressant treatment spells having increased in Finland (Sihvo et al.,
2010). However, thus far the causal connection between increased
antidepressant sales and a decline in suicide mortality remains open to debate
(Isacsson et al., 2010; Safer and Zito, 2007).
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3 EMPIRICAL EVIDENCE
3.1 SOCIAL DIFFERENTIALS IN DEPRESSION
OUTCOMES
The most consistent predictors of a negative course in depression seem to be
factors related to the depression itself: the severity of the index episode, the
number of previous episodes, early age at onset and psychiatric comorbidity
(Hardeveld et al., 2010; Steinert et al., 2014). Substance use disorders (SUD),
and  alcohol  use  disorders  (AUD)  in  particular,  are  common  in  depression
(Pirkola  et  al.,  2005;  Sullivan  et  al.,  2005)  and  have  been  found  to  predict
worse prognosis and suicidality (Blanco et al., 2012; Davis et al., 2008; Najt et
al., 2011; Sullivan et al., 2005).
Evidence of social differentials in depression outcomes remains
inconsistent. Reviews of studies using primary-care and community samples
report little or no evidence of differentials according to socioeconomic factors
or marital status in the recurrence or persistence of depression among adults
(Cole et al., 1999; Hardeveld et al., 2010; Licht-Strunk et al., 2007; Steinert et
al.,  2014).  On  the  other  hand,  a  meta-analysis  of  large  population  studies
(Lorant  et  al.,  2003)  as  well  as  more  recent  single  population  studies  have
indicated that depression is more persistent among the unemployed
(Bjerkeset  et  al.,  2008;  Bracke,  1998),  those  with  a  low  level  of  education
(Bjerkeset et al., 2008; Eaton et al., 2008; Lorant et al., 2003), a low income
(Lorant et al., 2003) and a low occupational social class (Lorant et al., 2003),
and those not owning their home (Dowrick et al., 2011).
Methodological  differences are likely to go some way in explaining these
inconsistencies. The reviews showing no social differentials only included
studies with rather small samples (n<500), which may not have had sufficient
statistical power to detect significant differences (Cole et al., 1999; Hardeveld
et al., 2010; Licht-Strunk et al., 2007). They were also based on more stringent
measurements, only including studies in which depression was diagnosed
according  to  DSM  or  ICD  criteria,  or  with  clinically  relevant  depressive
symptoms. In contrast, most studies included in the meta-analysis reporting
significant differentials used unspecific measures of psychological distress
such  as  the  GHQ,  and  in  only  one  study  was  depression  measured  in
accordance with a schedule based on DSM criteria. This study also showed the
smallest social-group differences in persistence (Lorant et al., 2003), possibly
indicating smaller social-group differentials in the persistence of depression
meeting diagnostic criteria.
Most studies assessing admission to psychiatric inpatient care, an indicator
of an unfavourable course of depression, report no differentials according to
socioeconomic or living-arrangement factors (Aro et  al.,  1995;  Callahan and
Wolinsky, 1995; Lauber et al., 2006; Lin et al., 2007; Morrow-Howell et al.,
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2006; Vogel and Huguelet, 1997), although one large register study revealed a
higher risk of readmission for depression among never-married individuals
(Kessing et al., 1998).
Empirical evidence of social differentials in depression mortality is largely
lacking. Most of the available studies focus on the predictors of suicide among
depressed patients. Research on suicide has yielded mixed results, some
showing higher and some lower risks among the unemployed, those who are
married or cohabiting, and those living alone (Hawton et al., 2013). As a result,
no significant social predictors were found in a meta-analysis of these studies
(Hawton  et  al.,  2013).  The  few  studies  assessing  causes  other  than  suicide
generally reveal no modification of excess mortality in depression. According
to  one  study  conducted  among  older  French  adults,  the  excess  all-cause
mortality of depression was unmodified by the number of social relations
(Fuhrer et al., 1999), whereas according to another one conducted among
discharged inpatients with depression, the excess risk of mortality for internal
and external causes was unmodified by marital status or education (Schneider
et al., 2001). A large register study on mortality after disability retirement on
the  grounds  of  depression  reports  a  largely  similar  excess  in  internal-cause
mortality across occupational social classes and living arrangements, whereas
the excess in external-cause and alcohol-related mortality was significantly
larger in the upper non-manual class and among those living with a partner
and children (Leinonen et al., 2014). These results provide little support for
the hypothesis that beneficial socioeconomic or family situations buffer
against the risk of premature mortality posed by depression.
Although  excessive  alcohol  use  has  been  suggested  as  one  of  the  major
pathways inducing depression mortality (Wulsin et al., 1999), few studies have
focused on alcohol-related mortality among the depressed, probably because
of  a  lack  of  suitable  data.  One  Finnish  study  reported  a  roughly  three-fold
increase in mortality from alcohol-related diseases and accidental alcohol
poisoning after disability retirement for depression, compared to non-retired
men and women (Leinonen et al., 2014), and another Finnish study based on
an employee sample reported a five-fold alcohol-disease mortality among
antidepressant users (Kivimäki et al., 2007). However, no studies have
explicitly assessed the contribution of alcohol-related causes to the excess
mortality associated with depression.
3.2 SOCIAL DIFFERENTIALS IN ANTIDEPRESSANT
TREATMENT
Inadequate and unequally distributed mental health care is a commonly raised
concern. It has been found that people with a high educational level (Andrews
et al., 2001; Blumenthal and Endicott, 1996; ten Have et al., 2004; Wang et
al., 2005) and a high income are more likely to seek and receive treatment for
their  mental  health  disorders  (Alegria  et  al.,  2000;  Wang  et  al.,  2005).  In
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particular,  receiving  care  that  meets  treatment  guidelines  and  is  given  in
specialised settings appears to be more common among those with a higher
socioeconomic position (Alegria et al., 2000; Wang et al., 2005; Young et al.,
2001). With regard to depression, evidence from Finnish population studies
suggests few social differentials in the receipt of treatment. It was found in a
sample of 557 depressed individuals that marital status, education,
occupational social class, household income and employment status were all
unrelated to the use of any or specialised healthcare for their major depressive
episode when severity of  the episode was controlled for (Hämäläinen et  al.,
2004).  In  a  smaller  population  sample  of  288  individuals  with  major
depressive disorder the only predictor of antidepressant use was being single,
and  of  psychological  treatment  was  being  divorced,  whereas  education,
income and employment status were unrelated to receiving treatment
(Hämäläinen et al., 2009).
Empirical evidence of social differentials specifically with regard to
antidepressant treatment is mixed, and varies according to which aspects of
socioeconomic  position  have  been  assessed.  According  to  most,  but  not  all
(Bocquier et  al.,  2013;  Hämäläinen et  al.,  2009; Harris  et  al.,  2011)  studies,
material aspects of a low socioeconomic position such as a low income
(Andersen  et  al.,  2009;  Hansen  et  al.,  2004a;  Mauramo  et  al.,  2012)  and
financial difficulties (Butterworth et al., 2013; Mauramo et al., 2012), as well
as unemployment (Andersen et al., 2009; Buffel et al., 2015; Colman et al.,
2008; Hansen et al., 2004a; Roer et al., 2010) predict a higher incidence and
prevalence of antidepressant use. However, analyses of aspects of
socioeconomic  position  related  less  directly  to  material  resources  and  more
directly  to  knowledge,  status  and  occupational  exposure,  namely  education
and occupational social class, indicate either no gradient (Butterworth et al.,
2013;  Colman  et  al.,  2008;  Hämäläinen  et  al.,  2009;  Harris  et  al.,  2011;
Kivimäki et al., 2007; Mauramo et al., 2012), or more antidepressant use
among  those  with  a  high  socioeconomic  position  (Andersen  et  al.,  2009;
Kivimäki et al., 2007; Roer et al., 2010).
The  key  challenge  in  assessing  the  extent  of  unequal  access  to
antidepressant treatment is the evaluation of differences in treatment need, in
other words differences in the prevalence and severity of depression. Most
studies do not have indicators for treatment need, although some infer
unequal access to antidepressant treatment by comparing their own results
with social differentials in depression incidence and prevalence from external
sources (Bocquier et al., 2013), or in depression outcomes such as suicide and
alcohol-related mortality (Kivimäki et al., 2007). These may be inappropriate
comparisons given that antidepressants are often prescribed for other
indications than depression (Gardarsdottir et al., 2007; Sihvo et al., 2008). If
the  social  patterning  in  these  other  indications  differs  from  depression
patterns, small social-group differentials in antidepressant use are likely to
emerge.
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Studies  explicitly  controlling  for  depression  severity  as  an  indicator  of
treatment need have reported equal use of antidepressants across educational
and  occupational  groups  (Butterworth  et  al.,  2013;  Colman  et  al.,  2008;
Hämäläinen et al., 2009; Harris et al., 2011), and either increased use among
those with fewer material resources such as a low income (Buffel et al., 2015;
Butterworth et al., 2013; Colman et al., 2008) or equal use across income and
employment groups (Hämäläinen et al., 2009; Harris et al., 2011). In contrast
with the hypothesis of unequal access to treatment, these findings have been
interpreted as an indication of an effective social safety net actually allowing
better access to treatment among the socially disadvantaged (Butterworth et
al., 2013).
Although social differentials in the incidence and prevalence of any
antidepressant use may be small, social inequalities may arise from
differentials in the adequacy of the dosage and the duration of the treatment.
In  particular,  common  predictors  of  non-adherence  such  as  a  low  level  of
medical  information,  a  lack of  social  support  and concerns about treatment
costs  (Mitchell  and  Selmes,  2007)  are  likely  to  be  more  common  among
patients with a low socioeconomic position. Accordingly, some studies,
although not all (Sihvo et al., 2008), report that early discontinuation is more
common (Hansen  et  al.,  2004b;  Jeon-Slaughter,  2012;  Sundell  et  al.,  2013)
and long-term antidepressant use less common (Bocquier et al., 2013) among
those with a  low socioeconomic position. However, few studies have assessed
social differentials in the longitudinal course and adequacy of antidepressant
treatment among depressed individuals.
3.3 ANTIDEPRESSANTS AND SUICIDE MORTALITY
Interest in whether antidepressant treatment prevents suicides is widespread,
and  researchers  have  used  various  designs  in  attempting  to  resolve  the
question. Randomised controlled trials, the gold standard of proving both
medication effects and causal effects more generally, have been largely
unhelpful in assessing such a rare outcome as suicide, and a lack of statistical
power has been a problem even in large meta-analyses of trials (Gunnell et al.,
2005).  As  a  result,  more  prevalent  outcomes  such  as  suicidal  ideation  and
behaviour have been assessed. These outcomes appear to be more common in
patients  treated  with  SSRIs  (Fergusson,  2005;  Gunnell  et  al.,  2005),
particularly among children and adolescents (Hammad et al., 2006).
However,  the  elevated  levels  of  suicidal  thoughts  and  behaviour  at  the
beginning of antidepressant treatment have been found to decrease in follow-
up as depressive symptoms dissolve (Gibbons et al., 2012). Consequently, the
short  follow-up  times  (8–10  weeks)  in  treatment  trials  may  hinder  the
assessment of potential long-term benefits (Gunnell et al., 2005).
A  meta-analysis  of  individual-level  observational  studies  with  longer
follow-ups ranging from two months to seven years revealed that the odds of
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completed suicide were 40 per cent lower among depressed adults and elderly
people using SSRIs (Barbui et al., 2009). Causal inference from observational
studies is challenged by the fact that patients are not randomised to treatment
groups.  Antidepressant  use  is  likely  to  be  influenced  by  suicide-risk  factors
such as depression severity, suicidal ideation and personal characteristics that
are difficult fully to control for (Barbui et al., 2009). This problem, referred to
as confounding by indication, is somewhat alleviated in aggregate-level studies
in  which  suicide  rates  are  predicted  by  regional  or  national  antidepressant
sales. The logic is on the population level: if antidepressants are effective in
suicide prevention, then increased antidepressant sales should translate into
a decline in suicide rates.
Most  aggregate-level  studies,  although  not  all  (Baldessarini  et  al.,  2007;
Safer and Zito, 2007; Zahl et al., 2010), indeed report declining suicide rates
as sales of antidepressants increase (Baldessarini et al., 2007; Gibbons et al.,
2005; Grunebaum et al., 2004; Gunnell et al., 2003; Gusmão et al., 2013; Kelly
et  al.,  2003; Ludwig et  al.,  2009).  However,  few of  these studies control  for
time, and thus it is difficult to establish whether the two trends are causally
connected or merely co-occurring. Controlling for time is essential in inferring
causality between trends in that it removes the confounding effects of all other
co-occurring trends in observed or unobserved factors such as other aspects in
the  provision  of  mental  health  care,  the  national  economy,  alcohol
consumption and divorce rates, which may influence suicide rates irrespective
of antidepressant sales. National studies from Sweden and Finland report no
beneficial effect after controlling for time (Dahlberg and Lundin, 2005;
Korkeila  et  al.,  2007),  whereas  it  was  found  in  a  Norwegian  study  that
increased sales reduced suicide rates in times of low antidepressant sales but
not when sales were high (Bramness et al., 2007). Ludwig and his colleagues,
in their time-controlled cross-national study, used between-country variation
in  how  rapidly  new  medication  is  adopted  and  diffused  nationally  as  an
instrument for antidepressant sales in predicting suicide rates (Ludwig et al.,
2009). They found a more rapid decline in suicide rates in countries with early
and  quick  diffusion  of  new medications—because  antidepressants  were  also
introduced more rapidly in these countries. Their results suggest a decrease of
five per cent in suicide rates for an increase of one pill per capita per day. An
instrumental  variable  approach  is  a  strong  test  for  causality  because  an
instrument  is  only  assumed  to  influence  the  outcome  via  its  effect  on  the
exposure of interest, and thus lacks problems related to confounding.
The evidence of a causal connection between increasing antidepressant
sales and decreasing suicide rates in national populations seems compelling.
However, it is unclear from the existing research whether increased
antidepressant sales have benefitted all population subgroups equally.
Subgroup-specific evidence is relevant given that the increase in
antidepressant treatment is likely to prevent suicides only among groups that
are adequately treated. Suicides are committed predominantly by men in a low
socioeconomic  position  (Mäki  and  Martikainen,  2009,  2008),  whereas
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antidepressants are consumed primarily by women and the socioeconomic
patterning of antidepressant use is less clear (see Chapter 3.2. Social
differentials in antidepressant treatment). According to a review of aggregate-
level studies, the decline in female suicide rates has been less strongly related
to  the  introduction  of  new  antidepressants  than  in  male  suicide  rates
(Baldessarini et al., 2007), but none of the studies contributing to this result
controlled  for  time  and  thus  causal  inference  is  problematic.  No  previous
studies have assessed the effects of antidepressant use on suicide across
socioeconomic and living-arrangement groups.
Another limitation in the current literature is that little is known about the
effects of antidepressant use on alcohol-related suicides, in other words
suicides in which alcohol intoxication is a contributory cause. This is a
significant subtype, particularly in Finland where around 30–40 per cent of
all suicides are alcohol-related (Mäki and Martikainen, 2009, 2008).
Furthermore, evidence from earlier studies suggests that depression is
suboptimally treated among patients with suicides attempts or comorbid
alcohol use disorders (AUD) (Blanco et al., 2012; Suokas and Lönnqvist, 1995;
Suominen  et  al.,  2002).  Although  not  all  alcohol-related  suicides  are
committed by people with AUD, increased antidepressant treatment in this
high-risk group could have a beneficial effect in preventing alcohol-related
suicides. However, no previous studies on this are available.
30
4 THE CONTEXT AND THE AIMS OF THE
STUDY
4.1 THE FINNISH CONTEXT
This study is set in Finland, a Nordic welfare state with tax-funded universal
healthcare and a nationwide health insurance scheme covering all permanent
residents irrespective of age, wealth or region of residence (National Agency
for Medicines and Social Insurance Institution, 2012; OECD, 2012; Wahlbeck
et al., 2008). Despite the intention to provide equally accessible healthcare,
concerns have been raised particularly related to the various pathways to care,
namely public outpatient services, occupational health services and private
health services, the latter two being available only to the employed and more
affluent sections of the population (Wahlbeck et al., 2008).
With regard to depression, Finland is a rather average European country.
The 12-month prevalence of depressive disorders (6.5% in Finland vs. a 6.9%
median across European studies) and differences in prevalence according to
education,  employment  and  marital  status  are  similar  to  those  reported  in
other  European  countries  (Lindeman  et  al.,  2000;  Pinto-Meza  et  al.,  2013;
Pirkola et al., 2005; Wittchen and Jacobi, 2005). Finland has a relatively high
suicide rate—in 2010 the age-standardised rate was 16.8 per 100,000 persons
compared  with  the  European  average  of  12.3  (OECD,  2012).  An  extensive,
nationwide suicide-prevention programme was implemented in Finland in
1992–1996, one of the major goals of which was to improve the detection and
treatment of depression (Beskow et al., 1999). The programme has been
evaluated as highly successful (Beskow et al., 1999; Upanne, 1999): the
detection and pharmacotherapy of depression have improved (Sorvaniemi et
al.,  2006) and suicide rates have declined since the beginning of  the 1990s,
although the causal connection between these developments has not been
empirically tested (Beskow et al., 1999; Upanne, 1999). Alcohol consumption
in Finland is below the European average (OECD, 2012), yet Finland has one
of the highest alcohol-related mortality in Western Europe (Ramstedt, 2002),
possibly because of more harmful drinking habits. Both alcohol consumption
and alcohol-related mortality  increased during the study period (Herttua et
al., 2007; National Institute for Health and Welfare, 2013).
Overall, the treatment of depression in Finland has been judged
inadequate. Less than a third of depressed people received any treatment for
their  depression  at  the  turn  of  the  millennium  (Hämäläinen  et  al.,  2009,
2004), and only 60 per cent of the patients who were given any treatment had
used specialist mental-health services in municipal psychiatric outpatient
clinics, mental-health centres, private psychiatrists or psychiatric hospitals
(Hämäläinen et al., 2004). Antidepressants are the most common treatment
for  depression  in  Finland  (Hämäläinen  et  al.,  2009).  They  are  sold  to  the
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public  only  by  authorised  pharmacies  against  a  prescription  issued  by  a
doctor—no over-the-counter medication is available (National Agency for
Medicines and Social Insurance Institution, 2012). All residents are eligible for
the  reimbursement  of  antidepressant  costs  as  part  of  the  public-health-
insurance scheme. The reimbursement level during the study period was 42
per  cent.  Drug  costs  are  directly  reimbursed  at  the  time  of  purchase,  the
reimbursement covering a maximum prescription period of three months at a
time (National Agency for Medicines and Social Insurance Institution, 2012).
There  is  also  an  annual  payment  ceiling  for  out-of-pocket  drug  costs,  after
which all further costs are fully reimbursed. A computerised individual-level
register of all reimbursed medications was created in 1994 to administer the
accumulation of out-of-pocket costs for patients (Klaukka, 2001). This
national Prescription Register is updated monthly from all retail pharmacies
and the information can be linked with other administrative registers using
personal identity codes given to all Finnish residents.
The availability of publicly financed psychotherapy was limited during the
study period. The demand far exceeded the supply in terms of available funds,
and there was also a shortage of psychotherapists outside urban areas
(Wahlbeck et al., 2008). Less than 20 per cent of depressed individuals in the
general population received any psychological treatment in 2000–2001
(Hämäläinen et al., 2009), and the proportion is suggested to be even lower
(around 10%) among people granted a disability  pension on the grounds of
depression (Honkonen et al., 2007).
The  Finnish  system  of  mental  health  care  has  been  described  as
fragmentary  and  complex  (Harjajärvi  et  al.,  2006;  Korkeila,  2009).  It  has
become highly decentralised since the deinstitutionalisation of psychiatric
care from the beginning of the 1990s (Korkeila, 2009). The municipalities are
currently responsible for arranging mental-health services for their residents,
either as part of their primary care provision or via services purchased from
larger hospital districts, private care providers and non-profit organisations
(Harjajärvi  et  al.,  2006;  Wahlbeck  et  al.,  2008).  There  is  large  variation
between municipalities in the extent and type of psychiatric outpatient
services available (Harjajärvi et al., 2006; Korkeila, 2009). psychiatric
inpatient  care  is  provided  in  psychiatric  hospitals,  the  psychiatric  wards  of
general  hospitals,  and  psychiatric  wards  under  the  administration  of
municipal health services (Harjajärvi et al., 2006; Kaltiala-Heino et al., 2001).
There  are  no  private  psychiatric  hospitals  in  Finland,  but  most  residential
services  for  psychiatric  patients  are  privately  run  with  municipal  funding
(Harjajärvi et al., 2006).
Treatment  of  substance  use  disorders  in  Finland  has  traditionally  been
separate  from  mental  healthcare,  and  services  are  mainly  provided  by
municipal social-care departments (Tammi and Stenius, 2014). Some types of
service  such  as  discussion  therapies  and  the  treatment  of  somatic  diseases
caused by substance use are also provided by the healthcare sector (National
Institute for Health and Welfare, 2013). The national plan for mental health
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and substance abuse work promotes the integration of outpatient services for
mental  health  and  substance  use  disorders  (Ministry  of  Social  Affairs  and
Health, 2012). However, the decentralised provision of services compromises
the potential for government steering and there are wide differences in service
integration among the municipalities (Tammi and Stenius, 2014). Alcohol use
disorders comprise the vast majority of substance use disorders in Finland.
For  example,  alcohol-related  causes  accounted  for  about  86  per  cent  of  all
substance-related inpatient care episodes in 2012, and over 90 per cent of all
substance-related deaths (National Institute for Health and Welfare, 2013).
This study covers a period of constant economic growth between two large-
scale economic downturns: the great recession at the beginning of the 1990s
and the recession following the financial crisis in 2008.
4.2 THE AIMS OF THE STUDY
The  overall  aim of  this  study  was  to  examine  how the  adverse  outcomes  of
depression vary according to social factors such as socioeconomic position,
employment  status,  and  living  arrangements,  and  to  establish  the  role  of
alcohol  and  antidepressant  treatment  in  bringing  about  this  variation.  The
study used large longitudinal register-based data for representative samples of
working-age and older Finns.
The specific aims were:
1. To assess the social  differentials  in the psychiatric  admission risk for
depression, in the excess mortality of depression, and in antidepressant
use (Sub-studies I-III).
2. To quantify the contribution of alcohol-related causes of death on the
excess mortality of depression (Sub-study II).
3. To establish whether increased sales of antidepressants caused the fall
in suicide rates in Finland,  and whether the effect  was similar across
population subgroups and for alcohol-related and non-alcohol-related
suicides (Sub-study IV).
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5 MATERIALS AND METHODS
5.1 DATA SOURCES AND STUDY DESIGNS
The analyses were based on longitudinal individual-level population register
samples  combining  information  from  various  administrative  registers.  The
personal identity codes given to all permanent residents of Finland were used
to link the different information. Annually updated data on socioeconomic
position,  employment  status,  living  arrangements,  and  dates  and  causes  of
death  were  obtained  from  Statistics  Finland.  Hospital  discharge  records
including  the  diagnoses  and  exact  dates  of  entry  and  exit  came  from  the
national Hospital Discharge Register held by the National Institute for Health
and  Welfare  (THL).  The  Social  Insurance  Institution  (Kela)  provided
information on all purchases of prescription medication from retail
pharmacies, including dates, amounts and type, drawn from the national
Prescription Register, as well as information on the right to reimbursement for
drug costs under the Special Refund Categories due to certain diagnosed
chronic conditions.  Information on alcohol-related deaths was based on the
underlying and contributory causes of death given on the death certificate and
came from the Statistics Finland Cause of Death Register. Register data
facilitate  the  longitudinal  assessment  of  depression  outcomes  in  a  large
population-based sample, with minimal attrition or loss to follow-up that may
be critical problems in clinical and survey-based studies (Fischer et al., 2001).
Validity studies have shown these register sources to have good quality  and
practically complete national coverage (Haukka et al., 2007; Lahti and
Penttilä, 2001; Mathers et al., 2005; Rikala et al., 2010; Sund, 2012; Sund et
al., 2014).
The first two sub-studies were based on a 14-per-cent random sample of
the Finnish population aged 40 years and older at the end of 1997, whereas the
third  and  fourth  were  based  on  an  11-per-cent  sample  of  the  Finnish
population  aged  15  years  and  older  in  1987-2007.  The  latter  sample  was
further supplemented with an oversampling of people who died, covering 80
per cent of all deaths occurring during the study period. The register holders
approved of the use of these linked datasets for research purposes (permission
numbers TK-53-574-04 and TK-53-373-09 for sub-studies I and II, and TK-
53-1519-09  for  sub-studies  III  and  IV).  Table  1  summarises  the  main
characteristics of the study samples and designs.
Sub-study  I  was  based  on  a  cohort  design  with  a  baseline  population  of
people  aged  40–64  years,  living  in  private  households  at  the  end  of  1997
(n=237,469).  Those  living  in  institutions  were  not  included  because
information on antidepressant purchases (one of the main indicators of
depression  used  in  this  sub-study)  was  not  available  for  this  group.  People
aged 65 and older were not included either because many of the social factors
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of interest, such as employment status and co-residence with minor children,
generally  applied  to  the  working-age  population.  Furthermore,  it  has  been
shown that the relationship between antidepressant use and depression is
weaker among older adults (Sihvo et al., 2008), and antidepressant use would
thus have been a less valid indicator of depression than among the working-
age population. The sample was assessed for baseline psychiatric morbidity in
1996-1997 using data on primary diagnoses of inpatient hospital care, the right
to special reimbursement for drug costs for certain diagnosed conditions, and
purchases of psychotropic medication (see Chapter 5.2.2   Psychiatric  and
somatic comorbidity for details). In order to focus on the outcomes of unipolar
depression, individuals with more serious psychiatric disorders such as
schizophrenia  and  bipolar  disorders  (n=5,658)  as  well  as  those  with  any
missing data (n=118) were excluded. Finally those in psychiatric hospital care
at  baseline (n=64) were excluded as,  by definition,  they were not at  risk for
hospital  admission  for  unipolar  depression,  the  outcome  of  interest  in  this
sub-study. The remaining sample (n=231,629) was divided into three groups
according to depression status in the two years preceding baseline: those with
inpatient care for unipolar depression, those with antidepressant purchases
and  those  with  neither  in  1996–1997.  These  groups  were  followed  up
separately  for  inpatient  hospital  admission  with  a  primary  diagnosis  of
unipolar depression in 1998–2003.
The baseline sample and study design in sub-studies I and II were broadly
similar.  However,  those  in  psychiatric  inpatient  care  at  baseline  were  not
excluded  in  sub-study  II.  The  sample  was  followed  up  for  cause-specific
mortality in 1998–2007, during which a total of 15,081 deaths were observed.
The mortality rates were compared according to depression status at baseline,
and  in  order  to  establish  whether  or  not  economic  and  social  resources
buffered against the detrimental effect of depression, the magnitude of the
excess mortality of depressed patients was compared between social groups.
The  contribution  of  alcohol-related  and  other  causes  of  death  to  the  excess
mortality was also calculated in this study.
The focus in sub-study III was on educational differences in the prevalence
of antidepressant use among people aged 25–64 living in private households,
and  having  at  least  one  hospital-care  episode  with  a  primary  diagnosis  of
unipolar depression in 1998–2007 (n=7,249). Antidepressant use was
assessed in consecutive three-month periods before and after the first
hospital-care episode for depression. If this episode was immediately preceded
or followed by another hospital episode, with no days back in the community
in between, the episodes were treated as a single episode and the three-month
periods  were  calculated  before  and  after  this  combined  episode.  One
individual could be observed for up to 40 periods, five years before admission
and five years after discharge. However, only periods between the beginning
of 1998 and the end of 2007, when the individual was alive, aged 25–64 and
living in the community, were included in the analyses, and thus an individual
could contribute less than 40 periods of observation time. The prevalence of
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antidepressant use was calculated for each period only among individuals
eligible for that period.
Adults  aged  20  and  older  in  1995–2007  (n=950,158)  were  followed  up
yearly for alcohol-related (n=2,859) and non-alcohol-related (n=8,632)
suicide in sub-study IV. Suicide risk was predicted by regional antidepressant
sales controlling for regional  differences and national-level  time trends that
may influence suicide risk irrespective of the regional sales. The effects of
antidepressant sales on suicide risk were assessed across relevant population
subgroups to establish whether the increased sales affected all groups
similarly.
Table 1. Data sets used in the sub-studies
Sub-study Sample Ages Study period N Dependent variables
I 14% community
sample from 1997
40–64 1997–2003 231,629 Psychiatric hospital
admission for
depression
II 14% community
sample from 1997
40–64 1997–2007 231,695 Cause-specific
mortality
III 11% population
sample from 1998–
2007 and 80% of
those dying in 1998–
2007 (only non-
institutionalised
individuals with at
least one hospital
episode for
depression)
25–64 1998–2007 7,249 Antidepressant use
IV 11% population
sample from 1995–
2007 and 80% of
those dying in 1995–
2007
20+ 1995–2007 950,158 Alcohol-related and
non-alcohol-related
suicide
5.2 VARIABLES
5.2.1 DEPRESSION
In this study depression was assessed indirectly using data on hospital care
and antidepressant purchases, which are the main indicators available in
register data (Thielen et al., 2009). Baseline depression status was measured
in the two years (1996–1997) preceding baseline in sub-studies I and II, and
during  the  whole  follow-up  period  (1998–2007)  in  sub-study  III.  The  exact
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criteria and terminology varied somewhat across the sub-studies, and this is
indicated in the text when appropriate.
Inpatient hospital care with a primary diagnosis of depression in
psychiatric or general hospital wards was used to measure depression in sub-
studies I–III. Depressed inpatients had hospital care for the following
diagnoses,  coded  according  to  the  International  Classification  of  Diseases
Tenth Revision (ICD-10): depressive episode (F32), recurrent depressive
episode (F33), dysthymia (F34.1), recurrent brief depressive episodes (F38.1),
and  postpartum  depression  (F53.0).  A  subject  who  had  hospital  care  for
depression was defined as an inpatient irrespective of his or her
antidepressant purchases.
Purchasing antidepressants was used as a proxy measure for being in
outpatient  care  for  depression  in  sub-studies  I  and  II. Depressed
outpatients had purchases of antidepressants but no inpatient hospital care.
Antidepressants included codes N06A in the Anatomical Therapeutic
Chemical  Classification  (ATC).  In  order  to  focus  on  depression,  tricyclic
antidepressants (codes N06AA but not N06AA22) were excluded as they are
often used for non-psychiatric indications (Gardarsdottir et al., 2007).
Although  also  non-tricyclic  antidepressants  have  indications  other  than
depression, such as anxiety, eating disorders, pain, incontinence, and
insomnia (Gardarsdottir et al., 2007) the main use in Finland is for depression
(Sihvo et al., 2008).
In sub-study II depressed outpatients were defined as having made at least
one non-tricyclic antidepressant purchase in the two years preceding baseline.
The definition was stricter in sub-study I: depressed outpatients had to have a
minimum of two yearly purchases or purchases of  at  least  90 Defined Daily
Doses  (DDD)  of  any  non-tricyclic  antidepressant  in  the  two-year  period
preceding baseline. DDD is the assumed average daily dose of a given drug for
its  main  indication  in  adults,  set  by  the  World  Health  Organization  (WHO
Collaborating Centre for Drug Statistics Methodology, 2013), and information
on  the  number  of  DDDs  purchased  was  obtained  from  the  Prescription
Register held by Kela.
Depression severity was assessed in sub-studies I and III. The psychotic
features of depression (F32.3 and F33.3) were used as a proxy for depression
severity among depressed inpatients (sub-studies I  and III).  The number of
DDDs was used in sub-study I as a proxy for the baseline severity of depression
among outpatients with larger amounts, indicating more severe depression.
The categories were less than 90,  90–179,  180–359,  360–719 and over 720
DDDs in the two-year period preceding baseline. These categories reflect daily
use for less than three months, between three and six months, between six and
12 months, for a year to two years, and for over two years, respectively.
Subjects with neither inpatient care for depression nor the required
number of antidepressant purchases were defined as non-depressed in sub-
studies I  and II.  It  should be noted that  this  group included non-depressed
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people but also depressed individuals with no inpatient or antidepressant
treatment.
In  sub-study  I  depressed  inpatients  were  termed  as  having  a  ‘baseline
history of inpatient treatment’,  depressed  outpatients  as  having  a  ‘baseline
history of antidepressant treatment’,  and  the  non-depressed  as  having  ‘no
baseline history of inpatient or antidepressant treatment’. However, for the
sake of clarity and consistency the terminology used in sub-studies II and III
is applied in this summary. All the dependent and independent variables used
in the sub-studies are listed in Table 2.
5.2.2 PSYCHIATRIC AND SOMATIC COMORBIDITY
Psychiatric comorbidity was assessed in sub-studies I–III, its measurement
being based on primary hospital diagnoses and purchases of psychotropic
medication.  Chronic  somatic  disorders  were  controlled  for  in  the  mortality
analyses of sub-study II, and were based on hospital diagnoses, purchases of
prescription medication, and the right to reimbursement for drug costs using
algorithms adapted  for  Finnish  health  registers  (Nihtilä  et  al.,  2008;  Sund,
2003).  Psychiatric  and  somatic  morbidity  were  measured  in  the  two  years
preceding baseline (1996–1997) in sub-studies I and II, and during the whole
follow-up period (1998–2007) in sub-study III.
In order to focus on unipolar depression in sub-studies I and II, individuals
with  more  serious  psychiatric  disorders  than  depression  (schizophrenia,  or
manic, bipolar or non-affective psychotic disorders) at baseline were excluded
irrespective  of  comorbid  unipolar  depression.  The  exclusion  was  based  on
hospital care (ICD-10 codes F20–F29, F30.1–F31, F53.1) and on the right to
special reimbursement for drug costs due to diagnosed psychosis. Individuals
with hospital care for other psychiatric disorders but not for unipolar
depression were also excluded because defining them as non-depressed or as
depressed outpatients using antidepressants would have made these groups
less meaningful.
Once  individuals  with  more  serious  psychiatric  disorders  had  been
excluded, as described above, other psychiatric comorbidity was assessed. The
measurement of comorbid substance use disorders (SUD) differed
slightly across the sub-studies. In sub-study III it only included hospital care
for substance-induced psychiatric disorders (ICD-10 codes F10–F19) and
alcohol intoxication (X45), whereas purchases of prescription medication for
SUD (ATC codes V03AA and V03AB30) were also included in sub-study I. A
more comprehensive definition was used in sub-study II to capture all alcohol-
related morbidity and thus also hospital care for substance-induced somatic
disorders (K29.2, K70, K86.0, I42.6, O35.4, G31.2, G40.51, G62.1, and G72.1),
and a more comprehensive list of prescription medications (N02AC02,
N02ACXX, N02AC06, N02AE01, N07BB, N07BC) was included.
Further psychiatric comorbidity among depressed inpatients was defined
in  sub-study  I  as  inpatient  treatment  for  other  psychiatric  disorders  (other
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ICD-10 codes F30–F69, F99, excluding unipolar depression, SUD and more
serious psychiatric disorders). Purchases of other psychotropic medication
(ATC codes N05A–N07, excluding non-tricyclic antidepressants) were used as
a  measure  for  comorbid  psychiatric  problems  among  depressed  outpatients
and non-depressed individuals.
5.2.3 SOCIAL FACTORS
Social  factors were measured at  baseline at  the end of  1997 in sub-studies I
and II, and as time-varying and updated annually in sub-studies III and IV. In
practice, measuring covariates as time-varying means reallocating each
individual annually according to changes in their status. An individual can
thus  contribute  to  the  population  at  risk  and  to  the  number  of  events  in
different  groups  in  different  years.  For  example,  an  individual  may  be  alive
and employed for one year and thus contribute a year of person-time to the
employed group. If the same individual is unemployed in the next year, and
commits suicide, he or she contributes less than a year of person-time and one
event  of  suicide  to  the  unemployed  group.  It  should  be  kept  in  mind  that
treating covariates as time-varying does not provide an estimate for the effect
of status change such as job loss, but only allocates events and populations at
risk more accurately.
Education was  based  on  the  highest  achieved  qualification,  classified
according to the International Standard Classification of Education (ISCED)
as  tertiary  (ISCED  levels  5–6),  secondary  (3–4)  and  basic  (0–2)  (UNESCO
Institute for Statistics (UIS), 2012). The two highest levels were collapsed in
sub-study IV. In sub-study III those enrolled in education for a higher degree
than the one already achieved were included in the higher categories, and the
two lower-level categories were collapsed. Thus the educational groups in sub-
study III were any and no post-secondary education.
Occupational social class was based on the classification of Statistics
Finland (1989) and included non-manual, manual and other. Economically
inactive persons were classified according to their  previous occupation,  and
homemakers  were  classified  according  to  the  occupation  of  the  head  of  the
household.
Household net income per  consumption  unit  was  calculated  by  first
summing  up  all  the  taxable  income  of  all  household  members  (including
wages, capital income and taxable income transfers, and excluding taxes), and
then dividing the sum by the number of consumption units in the household.
Consumption units were defined as 1.0 for the first household member and 0.7
for each of the other members. Household income was presented in quartiles.
Individual taxable income included wages, capital income and taxable
income transfers, without excluding taxes, and was divided into tertiles. The
two highest tertiles were collapsed and compared to the lowest.
Home ownership was categorised as owner and renter.
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Employment status was  classified  as  employed,  unemployed,  on
disability pension and other. The three last-mentioned groups were collapsed
in sub-studies III and IV, and compared with the employed group.
Living arrangements were  based  on  information  regarding  co-
residence and official marital status, categorised in sub-study I as living with
a marital or non-marital partner, not living with a partner and never having
been  married,  and  not  living  with  a  partner  and  having  previously  been
married. The two latter categories were collapsed in sub-studies II and IV, and
the partnered were compared to the non-partnered. Those living alone were
compared  with  all  the  others  in  sub-study  III.  Co-residence  with  minor
children was also assessed in sub-study I.
The demographic variables included gender, age, region of residence and
study year. All the analyses were either controlled for or stratified by gender.
Age was controlled for as categorical in sub-studies I, II and IV, and birth year
as continuous in sub-study III. Region of residence was categorised according
to the Nomenclature of Territorial Units for Statistics (NUTS) level 3 in sub-
studies I and IV, and level 2 in sub-study III (Eurostat, 2013).
5.2.4 OUTCOMES OF DEPRESSION
The measurement used in sub-study I for the unfavourable course of
depression was admission to hospital care with a primary diagnosis of unipolar
depression (ICD-10 codes F32–F33, F34.1, F38.1, F53.0).
Sub-studies II and IV assessed suicides and other mortality as depression
outcomes. Deaths were classified as suicides (ICD-10 codes X60–X84, Y87.0),
all accidental and violent deaths including suicides (V01–X44, X46–Y89), and
disease deaths including accidental alcohol poisoning (A00–T98, X45). They
were further divided into alcohol-related and non-alcohol-related based on
whether  alcohol  poisoning  (X45)  or  an  alcohol-related  disease  (F10,  G312,
G4051, G621, G721, I426, K292, K852, K860, O354, P043) was stated on the
death certificate as an underlying or contributory cause. Suicides were
considered alcohol-related if alcohol intoxication was stated as a contributory
cause on the death certificate.
5.2.5 ANTIDEPRESSANT TREATMENT
Sub-study III focused on antidepressant treatment received in consecutive
three-month periods before and after hospital care for unipolar depression. In
order  to  capture  the  pharmacotherapy  of  depression  as  comprehensively  as
possible all antidepressants (ATC codes N06A), including tricyclic
antidepressants (N06AA), were assessed. Sensitivity analyses excluding
tricyclic antidepressants yielded highly similar results. An individual was
defined as having any antidepressant use in a given three-month period
if he or she had purchased antidepressants at least once during the period, and
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as having daily antidepressant use if the purchases amounted to 90 DDDs
or more.
Yearly individual-level data on non-tricyclic antidepressant purchases were
aggregated in sub-study IV to produce regional antidepressant sales. Three
sales measures were assessed: (1) the regional number of DDDs sold per capita
per year to capture the amount of antidepressant medicine sold overall; (2) the
regional prevalence of antidepressant users to capture the proportion of the
population actually using antidepressants; and (3) the proportion with
purchases of at least 90 DDDs per year among all antidepressant users. The
last measure was used as an indicator of the proportion of antidepressant users
with minimally adequate treatment as it corresponds to a prescription of three
months or more, which is the general length of the acute-phase treatment of
depression (Hirschfeld, 2001). Given that current guidelines recommend
continuation treatment of between four and nine months after acute symptom
resolution (American Psychiatric Association, 2010; Depression: Current Care
Guidelines, 2014), sensitivity analyses were also conducted using the
proportion of individuals making purchases of at least 180 DDDs per year.
It  should  be  noted  that  DDDs do  not  measure  prescribed  daily  doses  as
such, but are a computational measure. The true prescribed daily doses
depend on patient characteristics such as age and weight, and may be larger
or  smaller  than  the  DDD  (WHO  Collaborating  Centre  for  Drug  Statistics
Methodology, 2013).
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Table 2.  Study variables in the sub-studies
Sub-study Dependent Independent
I Hospital
admission for
depression
Gender; Age (categorical 5-year age-groups)
Region of residence: NUTS3
Previous treatment: inpatient/antidepressant/neither;
Educational attainment: tertiary/secondary/basic;
Occupational social class: non-manual/manual/other;
Household net income quartile;
Home ownership: owner/renter;
Employment status: emp./unemp./disability pension/other;
Living arrangements: with partner/never marr./previously marr.;
Co-residence with children;
Severity of depression;
Substance use disorder;
Other psychiatric comorbidity;
II Suicide;
Accidental and
violent deaths;
Disease deaths;
divided into
alcohol-related
and non-alcohol
related
Gender (stratified); Age: categorical 1-year age-groups;
Depression status: inpatient/antidepressant/neither;
Educational attainment: tertiary/secondary/basic;
Home ownership: owner/renter;
Employment status: emp./unemp./disability pension/other;
Living arrangements: with partner/without partner;
Substance use disorder;
Chronic somatic disorders as dummy variables;
III Any
antidepressant
use; Daily
antidepressant
use
Gender; Year of birth (continuous);
Region of residence: NUTS2; Study year: continuous;
Educational attainment and enrolment: any post-secondary/no
post-secondary;
Employment status: employed/unemployed/other;
Living arrangements: alone/with others;
Substance use disorder;
Severity of depression;
IV Alcohol-related
and non-alcohol-
related suicides
Gender (stratified); Age (categorical 15-year age-groups);
Region of residence: NUTS3; Study year: categorical;
Regional non-tricyclic antidepressant sales (continuous): Doses per
capita; prevalence of users; proportion of users with minimally
adequate treatment;
Education: 9+ years/9 or less
Individual taxable income tertile: 2nd or 3rd/lowest
Home ownership: owner/renter
Employment status: emp./other
Living arrangements: with partner/without partner
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5.3 STATISTICAL METHODS
Social differentials in admission risk for depression (sub-study I) were studied
using Cox proportional hazards regression models (Singer and Willett, 2003).
Hazard ratios (HR) and their 95-per-cent confidence intervals were calculated
from multivariate models, controlling for demographic factors, baseline
severity of the depression, psychiatric comorbidity, and the social factors. The
analyses were performed separately for depressed inpatients (n=846),
depressed outpatients (n=8,754), and non-depressed individuals (n=222,029)
at baseline. Given that few gender interactions were significant, both genders
were  combined  in  the  analysis  in  order  to  gain  statistical  power.  Individual
follow-up times started at the end of 1997 and ended at hospital admission for
depression  (the  outcome  of  interest),  hospital  admission  for  a  more  severe
psychiatric  disorder,  emigration,  death or the end of  2003,  whichever came
first.
Mortality in depression was assessed in sub-study II by calculating gender-
and cause-specific mortality rates per 100,000 person-years during 1998–
2007 for depressed inpatients (n=897, 165 deaths), depressed outpatients
(n=13,658, 1,356 deaths) and the non-depressed population (n=217,140,
13,560 deaths) at baseline. The contribution of each cause to the total excess
mortality of depressed inpatients and outpatients was calculated from these
rates. The relative excess mortality was quantified in terms of mortality-rate
ratios with 95-per-cent confidence intervals for the combined depressed
inpatient and outpatient population compared with the non-depressed
population. Rate ratios were calculated using the Mantel-Haenszel method
(Clayton and Hills, 1993) controlling for age, inpatient status, SUD and other
chronic somatic disorders at baseline. To assess whether social factors such as
a  high  level  of  education,  home  ownership,  employment  or  living  with  a
partner buffered against the excess mortality of depression, the Mantel-
Haenszel method was used to test the effect modification by these factors,
controlling  for  age  and  inpatient  status.  Individual  follow-up  times  were
censored at death attributable to a cause other than the one studied, and at the
end of 2007.
Educational differences in the prevalence of antidepressant use were
assessed in sub-study III by means of logistic regression using generalised
estimating equations (GEE). GEE models take into account the dependency of
within-individual repeated measurements by assuming a correlation structure
between them (Twisk, 2004, 2003). An unstructured working correlation was
applied because it sets fewest restrictions on the correlation structure between
measurements (Twisk, 2004). The results are presented as crude and adjusted
differences between educational groups in the prevalence of antidepressant
use across time, and the 95-per-cent confidence interval for the difference.
Gender,  study  year,  year  of  birth,  region  of  residence,  comorbid  SUD,
depression severity, employment status and living alone were controlled for in
the adjusted model.
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Individual-level Poisson regression models (Loomis et al., 2005) were used
in sub-study IV to examine the extent to which regional antidepressant sales
predicted suicide risk in 1995–2007 among men and women aged 20 and older
(n=950,158). The yearly follow-ups were censored at death or end of year.
Robust  standard  errors  were  calculated  using  the  cluster-option  in  Stata  to
account  for  the  non-independence  of  yearly  follow-ups  of  the  same
individuals. A region and time fixed-effects approach was applied to control
for regional differences and national-level time trends that may influence
suicide risk irrespective of regional antidepressant sales. The region fixed
effects  control  for  all  time-invariant  regional  characteristics  such  as  the
prevalence of depression, whereas time fixed effects (as single-year dummy
variables) controls for variation in suicide risk common to all regions in a given
year irrespective of their antidepressant sales (Allison, 2009). Analyses were
conducted separately for different measures of antidepressant sales and for
alcohol-related and non-alcohol-related suicides, as well as for population
subgroups  by  gender,  education,  home  ownership,  employment  status,
income and living arrangements. The results are presented as suicide-
incidence rate ratios (IRR) and their 95-per-cent confidence intervals per one-
unit increase in regional antidepressant sales adjusted for age, region and year
fixed effects.
The  analyses  in  sub-studies  III  and  IV  were  weighted  to  account  for  the
oversampling of deaths in the data. The weighting produced similar estimates
as  would  have  been  obtained  by  analysing  the  11-per-cent  random  sample
alone  (without  the  oversampling  of  deaths),  but  the  precision  was  greatly
increased. Stata 8 and 11 (StataCorp, 2009, 2003) was used for all the analyses.
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6 RESULTS
6.1 HOSPITAL ADMISSION FOR DEPRESSION (SUB-
STUDY I)
Among middle-aged Finnish men and women 0.4 per cent had inpatient care
for depression in 1996–1997 and were thus defined as depressed inpatients.
Around three per cent of men and five per cent of women were depressed
outpatients (defined as having purchased at least 90 DDDs of antidepressants
or  at  least  twice  annually  in  1996–1997.  The  risk  of  subsequent  hospital
admission for depression was strongly dependent on baseline depression
status: almost 30 per cent of depressed inpatients were readmitted during the
five-year  follow-up  against  admission  of  only  around  five-per-cent  of
depressed outpatients, and less than one per cent among the non-depressed
population (Table 3).
Among depressed inpatients (Figure 1, Panel A), having the lowest income,
living in rented housing, being on disability pension and being never or
previously  married  increased  the  risk  of  readmission  by  20–50  per  cent.
However, these effects did not reach statistical significance in the full model in
which baseline severity, psychiatric comorbidity, demographics and all social
factors were controlled for simultaneously. Education, occupational social
class, unemployment and having coresident children were unrelated to
readmission risk among depressed inpatients.
The results  were fairly  similar for depressed outpatients (Figure 1,  Panel
B). Again, education and occupational social class were unrelated to admission
risk. Having the lowest income, living in rented housing, not being employed,
being previously married and not having coresident children increased the risk
by  25–60  per  cent  when  only  demographics  were  controlled  for.  However,
these effects were largely attenuated and failed to reach statistical significance
in the full  model.  Around half  of  the attenuation was due to adjustment for
baseline  severity  and  psychiatric  comorbidity  (35–70%  depending  on  the
variable), and half was due to mutual adjustment for all social factors.
 Social differentials in admission risk were larger among the non-depressed
population than among depressed inpatients and outpatients following
adjustment only for demographics (Figure 1, Panel C). All the measures of a
low socioeconomic position as well as not being employed, not living with a
partner and not having coresident children were strongly related to the risk of
hospital  admission  for  depression.  However,  the  effects  were  of  similar
magnitude as among the depressed groups in the full model. As there were no
measures for baseline severity in this group, most of the attenuation between
the models was due to mutual adjustment for all social factors.
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Table 3. Distribution of the study population in 1997 and the proportions admitted to
hospital for depression in 1998–2003 by depression status in 1996–1997 and
social factors in 1997: Finnish community-dwelling men and women aged 40–64
in 1997
Depression status
Inpatients Outpatients Non-depressed
Distribution Admitted Distribution Admitted Distribution Admitted
% % % % % %
Gender
 Men 47.8 23.7 38.3 5.4 50.2 0.5
 Women 52.2 34.6 61.7 5.0 49.8 0.6
Education
 Tertiary 20.9 27.1 29.0 5.1 25.7 0.5
 Secondary 32.5 32.0 34.4 5.6 33.6 0.7
 Basic or less 46.6 28.7 36.6 4.7 40.6 0.6
Occupational Social Class
 Non-manual 38.5 30.1 53.5 4.8 46.5 0.5
 Manual 43.6 29.0 30.4 5.6 36.5 0.7
 Other 17.8 29.2 16.1 5.5 17.1 0.5
Household income quartile
 Highest 15.7 24.8 24.7 4.4 25.4 0.4
 3rd 20.6 28.7 23.9 4.1 25.3 0.5
 2nd 24.5 29.9 23.0 4.7 25.1 0.6
 Lowest 39.2 31.4 28.4 7.1 24.1 0.9
Home ownership
 Owner 62.3 25.8 72.1 4.6 79.9 0.5
 Renter 37.7 35.4 27.9 6.6 20.1 0.9
Employment status
 Employed 31.8 26.8 50.6 4.8 65.6 0.5
 Unemployed 15.5 28.2 15.1 7.0 12.1 0.9
 Disability pension 43.1 31.3 26.1 4.6 12.2 0.8
 Other 9.6 32.0 8.3 6.1 10.1 0.6
Living arrangements
 With partner 52.1 25.6 61.8 4.5 74.0 0.5
 Never married 13.6 31.3 11.6 5.6 10.4 0.7
Previously
married 34.3 34.5 26.6 6.5 15.6 0.9
Coresident minors
 Yes 22.8 30.1 27.3 5.3 32.5 0.6
 No 77.2 29.2 72.7 5.1 67.5 0.6
All 100.0 29.4 100.0 5.2 100.0 0.6
N 846 249 8,754 452 222,029 1,320
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Figure 1 Hazard ratios of hospital admission for depression in 1998–2003 by social factors in
1997 and depression status in 1996-1997. Finnish community-dwelling men and
women aged 40–64 in 1997, *Statistically significant at the .05 level.
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6.2 MORTALITY IN DEPRESSION (SUB-STUDY II)
When the focus turned to mortality, depressed outpatients were defined more
broadly than in the study of  psychiatric  admission for depression.  Thus the
proportion of depressed outpatients, defined as having made at least one
antidepressant purchase in the two years preceding baseline, was larger: 4.4
per  cent  among  men  and  7.4  per  cent  among  women  (Table  4).  All-cause
mortality was three-fold among depressed male inpatients and four-fold
among depressed female inpatients compared with non-depressed men and
women, respectively. In the case of depressed outpatients, all-cause mortality
was around two-fold compared with the non-depressed in both genders.
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Table 4. Study population, number of deaths, mortality rate (per 1000 person years), and
deaths by cause in 1998–2007. Finnish community-dwelling men and women
aged 40–64 in 1997
Men Inpatients Outpatients Non-depressed
% 0.4 4.4 95.2
N 432 5061 109819
Number of deaths 103 788 9514
Mortality rate 27.5 16.9 9.0
Deaths by cause (%)
Suicides
 Alcohol-related 6.8 2.9 1.6
 Non-alcohol-related 10.7 4.9 2.3
Other accidental and violent deaths
 Alcohol-related 6.8 8.2 4.2
 Non-alcohol-related 4.9 6.0 3.8
Disease deaths
 Alcohol-related 25.2 27.9 18.7
 Non-alcohol-related 45.6 49.6 69.0
Unknown cause 0.0 0.4 0.3
Women Inpatients Outpatients Non-depressed
% 0.4 7.4 92.2
N 465 8597 107321
Number of deaths 62 568 4046
Mortality rate 14.3 6.8 3.8
Deaths by cause (%)
Suicides
 Alcohol-related 3.2 1.4 0.3
 Non-alcohol-related 27.4 5.1 1.5
Other accidental and violent deaths
 Alcohol-related 6.5 4.2 1.6
 Non-alcohol-related 4.8 5.5 3.1
Disease deaths
 Alcohol-related 12.9 15.8 8.7
 Non-alcohol-related 45.2 67.8 84.6
Unknown cause 0.0 0.2 0.2
Of  this  excess  mortality  suicides  accounted  for  around  10  per  cent  among
outpatient men and women, and around 25 and 40 per cent among inpatient
men and women, respectively (Figure 2). The majority (60–70%) of the excess
mortality was accounted for by disease deaths in all the other groups except
inpatient women. However, a large proportion of the excess disease deaths
were alcohol-related (45–60% among men and 30–35% among women).
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Overall, alcohol-related causes accounted for 45–55 and 25-35 per cent of all
excess deaths among men and women, respectively. All alcohol-related excess
deaths combined with non-alcohol-related accidental and violent deaths
accounted for around 70 per cent of the total excess among inpatient men and
women, and around 70 and 55 per cent among outpatient men and women,
respectively.
Figure 2 Proportion of excess mortality in 1998–2007 among depressed inpatients and
outpatients compared with the non-depressed population accounted for by different
causes of death. Finnish community-dwelling men and women aged 40–64 in 1997
Mortality rates in the non-depressed population were consistently higher
among those who had a low level of education, did not own their home, were
not  employed,  and  were  not  living  with  a  partner  (Table  5).  The  social
patterning of mortality was less clear in the depressed population (combining
inpatients and outpatients), and the differences between the social groups
were smaller. The relative excess mortality for all alcohol-related causes
among  the  depressed  was  significantly  larger  among  men  and  women  with
higher levels of education and employment. Furthermore, the excess mortality
for alcohol-related diseases was larger among those owning their home. The
relative  excess  mortality  of  the  depressed  was  not  significantly  modified  by
social factors in the case of non-alcohol-related causes.
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Table 5. Absolute mortality ratesa and mortality rate ratios (RR) in 1998–2007 by cause of
death, depression status in 1996–1997, and social factors in 1997. Finnish
community-dwelling men and women aged 40–64 in 1997
Alcohol-related Non-alcohol-related
Men Women Men Women
Dep.b
Non-
dep. RRc Dep.b
Non-
dep. RRc Dep.b
Non-
dep. RRc Dep.b
Non-
dep. RRc
Accidental and violent
deaths
Education  ** *
 Tertiary 157 28 4.92 49 3 16.50 114 33 2.94 93 11 5.04
Secondary 285 54 5.18 34 8 4.86 233 58 3.57 92 18 4.63
Basic 163 66 2.20 48 10 3.84 242 69 3.35 90 21 3.35
Home-ownership
Owner 136 41 3.13 36 5 6.58 173 46 3.42 68 16 3.26
Renter 369 98 3.55 64 18 3.37 279 97 2.70 154 24 5.19
Employment status * *
Employed 115 29 3.75 28 4 6.16 120 36 2.73 45 13 2.99
Unemployed 463 157 2.69 49 17 2.22 308 105 2.90 139 16 7.16
Disability 175 75 1.65 53 16 2.48 265 108 2.14 149 44 2.33
Living with partner
Yes 114 32 3.53 42 6 6.38 120 37 2.94 72 16 3.59
No 367 119 2.86 45 12 3.56 355 116 2.88 123 22 4.38
Disease deaths
Education  *  **
 Tertiary 321 72 3.98 66 14 4.24 620 374 1.44 283 201 1.29
Secondary 564 172 3.16 139 29 4.82 663 482 1.31 370 256 1.39
Basic 546 229 2.33 118 50 2.23 1245 899 1.41 674 464 1.46
Home-ownership * *
Owner 359 114 2.90 86 21 3.69 799 559 1.34 440 297 1.40
Renter 815 389 2.12 184 86 2.17 1052 879 1.26 558 436 1.27
Employment status *** *
Employed 269 72 3.54 66 16 3.90 380 323 1.17 233 184 1.21
Unemployed 842 493 1.65 197 98 1.71 593 755 0.87 377 342 1.18
Disability 559 358 1.27 163 71 1.93 1823 1927 1.05 1008 1043 1.05
Living with partner
Yes 267 89 2.81 99 27 3.67 805 527 1.40 417 283 1.39
No 897 425 2.10 132 50 2.30 993 928 1.14 560 436 1.33
Significant excess mortality in bold
Effect modification significant at level * P<0.05, ** P<0.01, *** P<0.001
a Per 100,000 person-years
b Depressed outpatients and inpatients combined
c Depressed vs. non-depressed, adjusted for age and inpatient status.
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6.3 ANTIDEPRESSANT USE TRAJECTORIES (SUB-
STUDY III)
Men and women with at  least  one hospital  episode for depression in 1998–
2007  were  followed  up  for  up  to  10  years,  splitting  the  follow-up  into
consecutive three-month periods before admission and after discharge. Of
these periods around 25 per cent were spent in any post-secondary education,
defined  as  high  education  (Table  6).  The  proportions  of  periods  with  any
antidepressant use and with daily antidepressant use were slightly larger
among those with a high as opposed to a low educational level (43% vs. 42%
and 31% vs. 29% for any and daily use, respectively). The highly educated were
more likely to be female and younger, and to have psychotic depression and
less likely to have had hospital care for substance use disorders (SUD) during
follow-up. Those with a high education were also more likely to be employed
and less likely to live alone than those with a low-level education.
Table 6. Characteristics of the study population (n=7,249) as means and proportions of
observed three-month periods by education. Finnish community-dwelling men
and women aged 25–64 with at least one hospital episode for depression in
1998–2007
Education
Low High
Any antidepressant use (%) 41.8 42.7
Daily antidepressant use (%) 28.6 30.8
Women (%) 53.3 61.0
Age (mean) 45.1 43.5
Psychotic depression (%) 11.4 15.6
Substance use disorder (%) 20.1 14.4
Employed (%) 39.5 61.6
Unemployed (%) 17.1 9.5
Living alone (%) 31.9 28.6
Weighted % 75.2 24.8
N (periods) 129,869 40,798
In the five years preceding hospital admission for depression there were no
differences between the educational groups in the prevalence of any
antidepressant use (defined as having made at least one purchase of
antidepressants in a given three-month period) (Figure 3). However, there was
a significant three-to-four-percentage-point excess in the prevalence of
antidepressant use among the highly educated in the three-month periods
immediately preceding admission and following discharge. The difference
widened  further  in  the  three-to-six-month  period  after  discharge  as  the
prevalence of any antidepressant use decreased more rapidly among the less
52
highly  educated.  This  excess,  ranging  from  three  to  six  percentage  points,
lasted for 2.5 years after discharge.
Figure 3 Excess in the prevalence of any antidepressant use among those with a high vs. a
low level of education before and after hospital care for depression with 95%
confidence intervals (CI). Finnish community-dwelling men and women aged 25–64
in 1998–2007. The adjusted model includes gender, birth year, study year, region of
residence, psychotic features, SUD, employment status, and living alone
Educational differences in the prevalence of daily antidepressant use
(defined  as  at  least  90DDDs  of  antidepressant  purchases  in  a  given  three-
month  period)  were  largely  similar  to  any  use  (Figure  4).  However,  the
prevalence of daily use was much lower. Even at its peak, immediately after
discharge, it was only 63 per cent among the highly educated and 55 per cent
among those with a low educational level, compared with 81 and 78 per cent,
respectively for any antidepressant use (data not shown). The differences
between the educational groups were also larger: between three and eight
percentage points up to 2.5 years after discharge.
Despite the large differentials in clinical and socio-demographic
characteristics,  controlling  for  these  factors  had  a  negligible  impact  on
educational differences in antidepressant treatment (Figures 3 and 4).
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Figure 4 Excess in the prevalence of daily antidepressant use among those with a high vs. a
low level of education before and after hospital care for depression with 95%
confidence intervals (CI), Finnish community-dwelling men and women aged 25–64
in 1998–2007. The adjusted model includes gender, birth year, study year, region of
residence, psychotic features, SUD, employment status, and living alone
6.4 ANTIDEPRESSANTS AND SUICIDE (SUB-STUDY IV)
Sales of non-tricyclic antidepressants increased rapidly in Finland in 1995–
2007. The number of daily doses sold per capita per year rose from five to 18
among  men  and  from  seven  to  30  among  women  aged  20  and  older.  The
prevalence of antidepressant users more than doubled, reaching over six per
cent among men and over 10 per cent among women in 2007. The proportion
of antidepressant users with doses reflecting minimally adequate treatment
(defined  as  having  purchased  at  least  90  DDDs  of  non-tricyclic
antidepressants  in  a  given  year)  increased  from  around  60  to  80  per  cent
among  both  men  and  women.  Simultaneously  with  this  increase  in
antidepressant sales, suicide rates declined among both men and women. The
age-adjusted rates fell from 56 to 38 suicides per 100,000 person-years among
men and from 16 to 11  among women. Around 30 per cent of  suicides were
alcohol-related among men and around 10 per cent among women.
Despite this temporal connection, regional sales of non-tricyclic
antidepressants  were  not  significantly  related  to  the  risk  of  any  suicide  or
alcohol-related suicide among men when age, region and year were controlled
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for  (Figure  5).  This  was  true  for  all  measures  of  antidepressant  sales:  the
number of doses sold per capita, the prevalence of antidepressant users and
the proportion among antidepressant users who had purchased doses
reflecting  minimally  adequate  treatment.  However,  the  risk  of  non-alcohol-
related male suicide was reduced by one per cent (incidence rate ratio,
IRR=0.987, 95% confidence interval 0.976–0.998) when the proportion
receiving minimally adequate treatment increased by one percentage point.
This significant result was not replicated in sensitivity analyses in which
minimally adequate treatment was defined as having purchased at least
180DDDs (data not shown).
Figure 5 Relative changes in suicide risk as incidence rate ratios (IRR) and 95% confidence
intervals per one-unit increase in regional non-tricyclic antidepressant sales (doses
sold per capita, prevalence of antidepressant users, proportion of antidepressant
users with doses reflecting minimally adequate treatment) controlled for age, region
and year fixed effects in Finland, 1995–2007, men aged 20+.
No measure  of  regional  antidepressant  sales  was  related  to  the  risk  of  any,
alcohol-related or non-alcohol-related suicide among women when age,
region and year fixed effects were controlled for (Figure 6).
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Figure 6 Relative change in suicide risk as incidence rate ratios (IRR) and 95% confidence
intervals per one-unit increase in regional non-tricyclic antidepressant sales (doses
sold per capita, prevalence of antidepressant users, proportion of antidepressant
users with doses reflecting minimally adequate treatment) controlled for age, region
and year fixed effects in Finland, 1995–2007, women aged 20+.
Further investigation into social-group differentials in the effect of
antidepressant sales on suicide risk was limited to the association between
non-alcohol-related male suicide and the proportion of antidepressant users
with minimally adequate treatment, because none of the other associations
were significant in the overall model. The reduction in suicide risk was only
significant among men who did not own their home and were not living with
a partner (Figure 7). The reduction was borderline significant among men with
higher levels of education, employment and income. There was no reduction
in suicide risk in the other groups.
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Figure 7 Relative change in non-alcohol-related suicide risk as incidence rate ratios (IRR)
and 95% confidence intervals per one-unit increase in the proportion of
antidepressant users with doses reflecting minimally adequate treatment by social
factors controlled for age, region and year fixed effects in Finland, 1995–2007, men
aged 20+.
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7 DISCUSSION
7.1 A SUMMARY OF THE MAIN RESULTS
This study used Finnish longitudinal data-sets combining information from
different administrative registers to investigate the outcomes of depression.
The overall objective was to assess the extent to which adverse outcomes vary
according to social factors, and the role of alcohol and depression treatment in
bringing about this variation. The specific aims were to examine social
differentials in psychiatric hospital admissions for depression, the excess
mortality of depression, antidepressant use and the effect of antidepressant
sales on suicide mortality. Further aims were to quantify the contribution of
alcohol-related causes to depression mortality, and to disentangle the causal
impact of increased sales of antidepressants on the risk of alcohol-related and
non-alcohol-related suicide.
Social differentials in psychiatric hospital admissions for depression, the
excess mortality of depression and antidepressant use were mainly small and
often non-significant. The most consistent predictors of hospital admission
were the material aspects of socioeconomic position, income, home ownership
and unemployment, as well as living without a partner. The excess mortality
of  depression  was  not  buffered  by  a  higher  socioeconomic  position,  being
employed, or having a partner. In contrast, the relative excess mortality
attributable to alcohol-related causes was somewhat larger in men and women
with a high level of education, the employed, and those owning their home. In
the case of non-alcohol-related causes the excess mortality was unmodified by
social factors. Antidepressant use before and after hospital care for depression
varied little across the educational groups, although the highly educated were
somewhat  more  likely  to  use  antidepressants  after  hospital  discharge.  The
differences were more pronounced in the case of daily rather than any use,
suggesting  more  below-guideline  use  among  those  with  a  low  educational
level.
The  findings  demonstrate  the  important  role  of  alcohol  in  depression
mortality. The contribution of alcohol-related causes to the excess mortality of
depressed  in-  and  out-patients  was  high,  accounting  for  around  half  of  the
excess mortality among men and around a third among women. The beneficial
effect of increased antidepressant sales in preventing suicides was limited to
non-alcohol-related male suicides, and was related to the increased proportion
of antidepressant users receiving minimally adequate treatment. These results
are discussed in more detail below.
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7.1.1 MODEST EFFECTS OF SOCIAL FACTORS
Psychiatric admission for depression
According to the results of this large, population-based study including both
depressed inpatients and outpatients with antidepressant purchases, social
factors such as socioeconomic position, employment status and living
arrangements have only modest predictive power in psychiatric admission for
depression. These results further strengthen the findings from mainly small
clinical and community samples (Cole et al., 1999; Hardeveld et al., 2013,
2010; Lauber et al., 2006; Licht-Strunk et al., 2007; Lin et al., 2007; Morrow-
Howell et al., 2006; Spijker et al., 2004, 2001b; Steinert et al., 2014; Vogel and
Huguelet, 1997) and larger population studies (Aro et al., 1995; Callahan and
Wolinsky,  1995)  that  social  factors  play  a  modest  role  in  determining
depression outcomes such as recurrence, persistence and psychiatric
admission.
The  results  are  somewhat  at  odds  with  those  of  previous  large-scale
population studies showing substantial differentials in depression persistence
according to education, occupational social class, income and employment
status (Bjerkeset et al., 2008; Bracke, 1998; Lorant et al., 2003; Melchior et
al.,  2013),  and  a  higher  risk  of  hospital  readmission  for  depression  among
never-married individuals (Kessing et al., 1998), possibly reflecting
methodological differences in the measurement of depression and its
outcomes. Most importantly, depression status was inferred in the current
study from healthcare use, and social differentials in outcomes may be smaller
among depressed individuals who are already in contact with the healthcare
system.
The  small  social  differentials  in  depression  outcomes  are  broadly
consistent  with  the  kindling  model  of  affective  disorders,  which  predicts  a
diminishing effect of life stressors on the recurrence of depression compared
with first onset (Monroe and Harkness, 2005; Post, 1992). Although the social
factors assessed in this study did not directly measure stressors, they indicate
differential exposure to life stressors such as union dissolution, job loss and
financial strain.
With regard to the relative importance of the different aspects of
socioeconomic position and living arrangements, the more material aspects of
socioeconomic position (income, home ownership and employment) and
living  without  a  partner  seemed  to  be  the  most  influential  risk  factors  for
admission, whereas differentials between educational and occupational
groups  were  negligible.  A  similar  pattern  has  typically  emerged  in  studies
assessing the incidence and prevalence of depression (Andersen et al., 2009;
de  Graaf  et  al.,  2012;  Eaton  et  al.,  2008;  Hughes  and  Waite,  2002;
Joutsenniemi  et  al.,  2006;  Kessler  et  al.,  1997;  Kosidou  et  al.,  2011a;
Laaksonen et al., 2007; Lorant et al., 2003; Pirkola et al., 2005). There may be
at least two explanations for this finding. First, the social factors that were
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more strongly related to depression outcomes (income, home ownership,
employment and living arrangements)  are more dynamic than education or
occupational  social  class  and  are  thus  more  likely  to  be  affected  by  reverse
causality. In other words, an unfavourable course of depression may lead to
union  dissolution  or  exclusion  from  the  labour  market,  but  cannot  change
previously  obtained  educational  qualifications  or  occupation  (at  least  when
measured retrospectively from previous occupation among those not currently
employed, as in the current study). It may also be that residual confounding
by  the  severity  of  baseline  depression  and  psychiatric  comorbidity,  which
could not be fully accounted for, affected both the dynamic social factors and
the depression outcome. It was found in a Belgian study, for example, that the
higher risk of depression persistence among highly educated and divorced
individuals  was  fully  accounted  for  by  differences  in  baseline  depression
severity (Bracke, 1998).
On the other hand, economic resources and living with a partner could well
have  a  stronger  causal  impact  on  depression  outcomes  than  education  and
occupational class. Economic resources such as employment and income may
be particularly critical to coping with depression on account of lower levels of
stress related to financial difficulties and economic insecurity, better access to
occupational health services, and better affordability of treatment. A high
education and a non-manual occupational social class may provide few
additional resources. In contrast, psychosocial exposures such as demanding
and stressful work among the highly educated and in non-manual occupations
could, in fact, make it more difficult to cope with depression in these groups.
The lower prevalence of  depression among people living with a partner has
previously been found to be partly mediated through social support and better
health behaviours (Joutsenniemi et al., 2006), and the same could apply in the
case of depression outcomes. Specifically, co-resident partners may encourage
care-seeking and enhance treatment adherence. The emotional support and
optimistic outlook provided by a partner are also likely to have a direct positive
effect on coping with depression. Further research is needed to disentangle the
causal direction and the specific pathways bringing about the observed social
differentials in psychiatric admission for depression.
The excess mortality of depression
The findings related to depression mortality provided little support for the
hypothesis  that  social  and  economic  resources  would  buffer  against  the
detrimental effect of depression. Excess mortality among the depressed varied
relatively little by social factors, particularly for non-alcohol-related causes.
This further strengthens the evidence from previous studies based on smaller
samples (Fuhrer et al., 1999; Schneider et al., 2001). In contradiction of the
buffering hypothesis, in fact, the relative excess mortality of depression in the
case  of  alcohol-related-causes  was  significantly  larger  among  those  with  a
higher education, those owning their home and the employed. It could be that
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fulfilling labour-market-related expectations when depressed is more
challenging  in  these  groups  (Agerbo,  2007),  resulting  in  excessive  alcohol
consumption. However, in these socioeconomic groups alcohol-related
mortality  was  very  low  in  the  non-depressed  comparison  group,  which
resulted in a large relative excess. The absolute excess in death rates was, in
contrast, generally larger among those with a low socioeconomic position, the
unemployed  and  those  living  without  a  partner.  In  accordance  with  these
findings, a study on excess mortality after disability retirement for depression
indicated that socioeconomic resources and family ties may be less protective
among people who have already developed depression than in the general
population  (Leinonen  et  al.,  2014).  The  results  on  both  mortality  and
psychiatric  admission  indicate  that  efforts  to  tackle  social  inequalities  in
depression  should  focus  on  the  primary  prevention  of  its  onset,  given  that
social differentials in outcomes, at least in a population already in contact with
the  healthcare  system,  are  small.  Furthermore,  the  impact  of  delayed  or
altogether lacking healthcare contact on social differentials in depression
outcomes should be investigated in future studies.
Antidepressant use
The educational differences in antidepressant use before and after hospital
care for depression identified in this study were small, and mostly driven by
earlier discontinuation and below-guideline treatment among those with a low
level of education. Differences in antidepressant use were assessed among
people with hospital care for depression in order to overcome a common
setback in earlier studies, namely the lack of information on treatment need
across  socioeconomic  groups  (Andersen  et  al.,  2009;  Hansen  et  al.,  2004a;
Kivimäki  et  al.,  2007).  Hospital  care  for  depression  was  considered  an
indication  of  an  evident  need  for  treatment  that  would  be  reasonably
homogenous across educational groups. The small educational differences in
any antidepressant use in the three months following hospital discharge
suggests  rather  equitable  access  to  at  least  some  treatment  at  the  time  of
evident  need.  This  is  in  accordance  with  findings  from  previous  studies
controlling  for  depression  severity  as  an  indicator  of  treatment  need
(Butterworth  et  al.,  2013;  Hämäläinen  et  al.,  2009;  Roer  et  al.,  2010).
However, in line with earlier evidence showing higher discontinuation rates
among those with a low socioeconomic position (Bocquier et al., 2014; Hansen
et  al.,  2004b;  Sundell  et  al.,  2013),  the  prevalence  of  antidepressant  use
declined more rapidly among those with a low level of education.
Furthermore, daily antidepressant use was more common among those
with a high education, and the differentials were more pronounced than for
any use. The differentials were particularly large immediately after discharge,
suggesting a need for improved treatment adherence among the less highly
educated. It has been concluded in earlier Finnish studies that continuity is
the main challenge in the treatment of depression (I. A. Holma et al., 2008;
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Melartin et al., 2005), and this seems to be particularly true among those with
a low level of education.
Although the educational differences in antidepressant use were
significant,  especially  after  discharge  from hospital  care  for  depression,  the
differences in prevalence were quite small, eight percentage points at the
highest. This may reflect the fact that the national public health insurance and
social  security  system  in  Finland  lowers  the  financial  barriers  to  treatment
among those with a low educational level. Public health insurance covers 42
per cent of the price of antidepressants for all patients irrespective of wealth
(National Agency for Medicines and Social Insurance Institution, 2012).
Furthermore,  the  costs  of  medicines  and  healthcare  services  may  be  fully
covered by social assistance, a last-resort form of economic assistance
provided by municipalities for individuals and families whose income does not
suffice  to  cover  living  expenses  (National  Agency  for  Medicines  and  Social
Insurance Institution, 2012; Wahlbeck et al., 2008).
It should be noted that this study only assessed antidepressant treatment,
information  on  other  forms  of  depression  treatment  being  unavailable.
Treatment guidelines recommend combining antidepressants with
psychotherapy  as  the  most  effective  treatment  (Cuijpers  et  al.,  2014b;
Depression: Current Care Guidelines, 2014). Differentials between
socioeconomic  groups  could  be  larger  when it  comes  to  psychotherapy  and
other types of psychological treatment provided by occupational health
services, private healthcare providers and municipal outpatient services. In
particular,  the  shortage  of  publicly  funded  psychotherapy  (Wahlbeck  et  al.,
2008) as well as financial barriers to private psychotherapy may prevent its
use among those in a low socioeconomic position.  It  was found in a British
study that  a  high level  of  education,  a  high income and a high occupational
social class were all associated with higher usage of privately purchased
psychotherapy, whereas differences in publicly funded psychotherapy were
smaller  and even reversed (Jokela et  al.,  2013).  In contrast,  a  Finnish study
reported no differences according to education, income or employment status
in  any  (private  or  public)  psychological  treatment  among  individuals  with
major depression in the previous 12 months (Hämäläinen et al., 2009).
Given  that  the  Finnish  study  only  assessed  depressed  persons  and
controlled for measures of depression severity and comorbidity, it is likely to
give a more thorough insight into differentials in depression treatment,
whereas the British study covering the general population and with no controls
for depression reflects differentials in care use more generally. It is a common
finding that the majority of mental-health treatment is received by people with
mild  or  sub-clinical  symptoms  (Bijl  et  al.,  2003;  The  WHO  World  Mental
Health Survey Consortium, 2004). In fact, the British study revealed that most
people using private psychotherapy had only low levels of psychological
distress as measured by the GHQ (Jokela et al., 2013). It could thus be that, in
the  general  population,  those  in  higher  socioeconomic  positions  seek  more
treatment for minor symptoms because they have the financial resources to do
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so. However, this does not necessarily imply inequalities in access to treatment
among  those  with  major  depression.  Accordingly,  studies  reporting  that
antidepressant  use  is  more  common  among  those  with  a  high  level  of
education  or  in  a  high  occupational  social  class  (Andersen  et  al.,  2009;
Kivimäki et al., 2007; Roer et al., 2010) may be detecting differentials in its
use  for  minor  symptoms.  The  present  study  overcame  this  problem  in
assessing antidepressant use only among people with inpatient hospital care
for depression. However, further studies are needed to assess social
differentials in the initiation and continuation of antidepressant use, as well
as in antidepressant treatment combined with psychotherapy, among
depressed people in the general population: they may differ from those
observed in people already in contact with specialised psychiatric care.
7.1.2 IMPORTANT ROLE OF ALCOHOL IN DEPRESSION MORTALITY
Several reviews suggest that alcohol use is a major mediator in the depression-
mortality association (Cuijpers and Schoevers, 2004; Wulsin et al., 1999), but
studies  controlling  for  self-reported  alcohol  use  have  rarely  found  it  to
markedly attenuate the excess mortality (Anda et al., 1993; Morris et al., 1993;
Mykletun et al., 2007; Shekelle et al., 1981). However, the under-reporting of
alcohol intake in self-reports as well as the under-representation of heavy
drinkers in surveys are common problems (Gray et al., 2013) that may lead to
underestimating the contribution of alcohol in these studies. This is the first
study to explicitly quantify the contribution of alcohol-related deaths in
depression mortality without the problems of distorted self-reporting or
selective non-response, and it demonstrates the important role of alcohol in
bringing  about  depression  mortality.  Around half  of  the  excess  mortality  of
depressed  patients  among  men  and  around  a  third  among  women  was
attributable to alcohol-related causes. Most of the deaths were attributable to
alcohol  diseases,  suggesting  long-term  excessive  alcohol  consumption  is  a
major pathway from depression to mortality, particularly among men.
However, it should be kept in mind that it was impossible in this study to
disentangle the temporal or causal ordering of depression and excessive
alcohol  consumption,  and  the  depressed  patients  dying  of  alcohol-related
causes could have been suffering from depression preceded or even caused by
alcohol use disorders. The causal association between alcohol use disorders
and  depression  seems  to  be  complex  and  bidirectional:  on  the  one  hand
alcohol use disorders may result from self-medication for depressive
symptoms, and on the other hand excessive alcohol consumption may cause
depression via social or physiological pathways (Swendsen and Merikangas,
2000). The disorders may also share common genetic and environmental risk
factors (Prescott et al., 2000). Irrespective of the reasons for comorbidity, the
results indicate that the detection and management of alcohol use disorders
and excessive alcohol consumption more generally are prerequisites in
reducing depression mortality.
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Overall, the results highlight the importance of behavioural and life-style
pathways in depression mortality among depressed inpatients and outpatients
using antidepressants. Alcohol-related causes, suicides and other violent and
accidental  causes  together  accounted  for  around  70  per  cent  of  the  excess
mortality  of  depressed  men,  and  55–70  per  cent  among  depressed  women.
This  could  be  considered  a  lower  limit  for  the  contribution  of  behavioural
pathways in that unhealthy lifestyles may also be linked to many non-alcohol-
related disease deaths. For example, smoking-related deaths have previously
been found elevated among Finnish women with depression (Joukamaa et al.,
2001): these were categorised as non-alcohol-related disease deaths in the
current study and were thus considered “non-behavioural”. A more detailed
decomposition of the causes of death contributing to the excess mortality of
depression would better capture the different pathways. Specifically, assessing
the contribution of alcohol-related deaths to the frequently observed excess
cardiovascular mortality among the depressed (Wulsin et al., 1999) could be a
fruitful direction for future study. Quantifying the extent to which excessive
alcohol consumption is behind the observed association would be particularly
interesting given that cardiovascular disease is the cause for which some of the
most plausible biological pathways have been suggested (Cuijpers and
Schoevers, 2004; Wulsin et al., 1999).
With respect to the external validity of the results, it may be that alcohol is
particularly  significant  as  a  pathway  for  depression  mortality  in  Finland,
where alcohol-related mortality overall is one of the highest in Western Europe
(Ramstedt, 2002). Self-medication of depression by means of alcohol could be
more common in Finland than in other countries, for example. This claim is
not, however, strongly supported by the finding that the 12-month prevalence
of comorbid alcohol use disorders among the depressed in Finland, at around
12  per  cent  (Pirkola  et  al.,  2005),  seems  to  be  similar  to  those  in  the
Netherlands (13–17%; Boschloo et al., 2011) and the United States (14%; Hasin
et  al.,  2005).  The  contribution  of  alcohol-related  causes  to  depression
mortality in the general population could also differ from that found in the
current study of depressed patients in treatment. Further research is needed
to establish the contribution of alcohol-related causes to depression mortality
across  countries  with  different  levels  of  alcohol  consumption  and  alcohol-
related mortality, in different treatment settings and in the general population.
7.1.3 LIMITED EFFECT OF ANTIDEPRESSANTS ON SUICIDE
he  study  findings  show  that  the  improved  adequacy  of  antidepressant
treatment may have prevented non-alcohol-related suicides among men in
Finland in 1995–2007. A one-percentage-point increase in the regional
proportion of antidepressant users receiving doses reflecting minimally
adequate treatment was related to a one-per-cent reduction in the risk of non-
alcohol-related male suicides when controlling for all time-invariant regional
characteristics and all national-level year-specific characteristics that could
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affect suicide risk irrespective of regional antidepressant sales. On the national
level this would suggest that increased adequacy of antidepressant treatment
could account for over half (63%; 95% confidence interval 11%–105%) of the
decrease in non-alcohol-related suicides, given the almost 20 percentage-
point increase in the proportion of men receiving minimally adequate
treatment. Finland implemented an extensive national suicide-prevention
programme in 1992–1996 (Beskow et al., 1999), which may have enhanced the
detection and adequacy of pharmacological treatment for depression
(Sorvaniemi et al., 2006). Enhanced treatment adequacy could be related to
increased adherence, given earlier findings that nonadherence is a major
determinant of early continuation (Melartin et al., 2005). However, further
research is needed to establish trends in antidepressant adherence.
Other  aspects  of  regional  mental-health  service  provision  in  addition  to
regional antidepressant sales, such as the density of general practitioners and
psychiatrists, and of available outpatient services, may affect suicide risks. It
has been found that Finnish municipalities with versatile, community-based
mental-health services have lower-than-expected suicide rates even when
socioeconomic and mental-health differentials between municipalities are
controlled  for  (Pirkola  et  al.,  2009).  Regional  differences  in  mental-health
service provision could be reflected in differential antidepressant sales, and
thus confound the antidepressant effect. Controlling for all stable differences
between regions in the region fixed effects reduced this confounding
somewhat in the analyses. However, co-occurring regional changes in service
provision were not controlled for. Consequently, their effects on suicide risk
will be attributed to changes in antidepressant sales, which may overestimate
the beneficial effect of increased sales.
Unlike some previous studies using similar methodology (Bramness et al.,
2007; Ludwig et  al.,  2009) this  study did not reveal  any beneficial  effect  of
increased overall per-capita sales or prevalence of antidepressant use. Given
that short-term and non-psychiatric antidepressant use is common (Sihvo et
al., 2008), a mere increase in overall sales or user prevalence may have little
impact on suicide risk—in particular if much of the increase  is accounted for
by treatment of mild and subclinical symptoms. The study also failed to show
a beneficial effect of increased antidepressant sales on alcohol-related or
female suicides. There may be methodological reasons for these null findings,
such as insufficient statistical power to detect beneficial effects (see Chapter
7.2.3. Fixed effects regression). More substantive explanations relate to the
study period and the targeting of treatment.
Previous studies with longer observation periods going back to 1980 have
shown a beneficial effect of increased overall sales only when antidepressant
sales were low (Bramness et al., 2007; Gusmão et al., 2013). The current study
covered a later period, 1995–2007, during which increases in already relatively
high antidepressant sales may no longer have reduced the number of suicides.
This may be particularly true for women, among whom prevalence and per-
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capita  sales  were  at  a  higher  level  than  among  men  throughout  the  study
period.
At least  two reasons could explain why alcohol-related suicides were not
affected by the increased sales. First, antidepressants may be less effective in
the presence of excessive alcohol use. However, this is not strongly supported
by evidence from studies on comorbid depression and substance use disorders
suggesting that antidepressants are effective in the treatment of both disorders
(Davis et al., 2010; Nunes and Levin, 2004). Second, there may have been less
increase in antidepressant treatment among people with a high risk of alcohol-
related suicide. The treatment of depression has previously been found
inadequate among patients with comorbid substance use disorders (Blanco et
al., 2012; Suominen et al., 2002). The detection may be hindered by comorbid
alcohol use disorders, and current treatment guidelines recommend the
postponement of antidepressant treatment initiation until substance use is
under control (Depression: Current Care Guidelines, 2014). Although more
research is  needed to establish how treatment adequacy has evolved in this
group following the expansion in antidepressant treatment, the current results
suggest that the increased availability of antidepressant treatment may not
adequately cover this group. Alcohol-related suicides are particularly common
among men and women with a low socioeconomic position, the unemployed,
and those not living with a partner (Mäki and Martikainen, 2009, 2008). More
rigorous preventive strategies focusing on alcohol-related suicides would
therefore also help in tackling social differentials in suicide mortality. In the
case of non-alcohol-related suicide mortality, the increased adequacy of
treatment had a beneficial effect among men living without a partner and not
owning  their  home.  This  result  implies  success  in  the  targeting  of
antidepressant treatment among these high-risk groups.
7.2 METHODOLOGICAL CONSIDERATIONS
7.2.1 REGISTER DATA
This study was based on large register samples representative of the Finnish
adult population, with long follow-ups. Individual-level records from various
administrative registers were linked using the unique personal identification
codes  given  to  all  permanent  residents  of  Finland.  These  data  carry  both
strengths and weaknesses in assessing the outcomes of depression. One of the
biggest strengths is that they do not suffer from non-response or attrition,
which can pose immense problems in clinical and survey studies of depression
outcomes  in  that  they  tend  to  be  associated  with  depression  severity,
demographic and social factors (Fischer et al., 2001), as well as high mortality
(Harald et  al.,  2007; Jousilahti  et  al.,  2005).  Register data also circumvents
problems  of  recall  bias  and  misreporting.  Specifically,  information  on  the
studied  outcomes  of  depression,  namely  psychiatric  hospital  care  for
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depression, suicide, and other premature mortality, is based on the national
Hospital Discharge Register and the Finnish Cause of Death Register, both of
which have been shown to have good quality and practically complete coverage
(Lahti and Penttilä, 2001; Mathers et al., 2005; Sund, 2012). The same applies
to  the  national  Prescription  Register  (National  Agency  for  Medicines  and
Social Insurance Institution, 2012) from which the information on purchases
of antidepressants and other medication was drawn. Several Finnish studies
report high concordance between registered antidepressant purchases and
self-reported antidepressant use (Haukka et al., 2007; Rikala et al., 2013,
2010). Although the accuracy of depression diagnoses in Finnish healthcare
registers has not been explicitly  assessed (Sund,  2012),  the universal  public
health insurance should minimise the incentives to biased diagnosing, such as
for reimbursement reasons. Finally, extensive register data are well suited to
the study of rare outcomes such as suicide. The major limitations of register
data concern the measurement of depression. These limitations are discussed
below.
7.2.2 THE MEASUREMENT OF DEPRESSION
Depression  was  measured  by  hospital  care  with  a  depression  diagnosis
(depressed inpatients) in sub-studies I–III, and in sub-studies I and II also by
registered purchases of antidepressants (depressed outpatients), which means
that  all  individuals  categorised  as  ‘depressed’  were  in  treatment.  This  has
significant implications for the interpretation of the results because studies
from the turn of the millennium indicate that only about a third of depressed
individuals in Finland used any healthcare services for their depression
(Hämäläinen et al., 2004), and only a quarter used antidepressants
(Hämäläinen et al., 2009). The propensity to seek treatment increased with
depression severity, duration, and perceived disability and healthcare use was
around 60 per cent among those with the most severe depressive episodes
(Hämäläinen  et  al.,  2004).  Although  data  from  Denmark  implies  the
possibility of differential misclassification across social groups when register-
based measures of depression are used, resulting in underestimation the
excess prevalence of depression in low social groups (Thielen et al., 2009), this
seems  not  to  be  the  case  in  Finland:  no  differences  were  found  in
antidepressant use according to education, income, employment status or
living arrangements among individuals with clinically assessed depression
when its severity was controlled for (Hämäläinen et al., 2009). Moreover, the
non-psychiatric use of antidepressants seems to be unrelated to education,
employment  status  or  living  arrangements  (Sihvo  et  al.,  2008).  Taken
together, the proxy measures for depression used in this study are not highly
sensitive, and mostly capture the more severe cases, but they are likely to do
this rather similarly across social groups. They will also capture depressed
individuals who are not picked up in the surveys due to selective non-response
(Markkula  et  al.,  2015).  Sensitivity  in  future  register  studies  on  depression
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could be increased by obtaining data from additional register sources covering
areas such as state-funded rehabilitation psychotherapy (available from 1994
onwards), specialised psychiatric outpatient care (available from 1998
onwards) and primary healthcare (available from 2011 onwards), although the
quality of such sources is unclear.
In terms of specificity, hospital diagnoses are likely to be rather accurate as
measures, although validation studies of the hospital discharge register have
not assessed depression diagnoses specifically (Sund, 2012). However, not all
people making antidepressant purchases are depressed. Antidepressants are
prescribed  for  many  indications  including  anxiety,  eating  disorders,  sleep
problems,  incontinence and pain,  although depression is  the most common
(Gardarsdottir et al., 2007; Sihvo et al., 2008). Unfortunately, information on
the diagnoses for which antidepressants were prescribed was not available in
the data. In order to minimise the misclassification of non-depressed people
as depressed, tricyclic antidepressants were excluded because they are
commonly used for non-psychiatric indications (Gardarsdottir et al., 2007;
Sihvo et al., 2008). Furthermore, sub-studies I and II, in which antidepressant
purchases were used as a proxy for depression, excluded people aged 65 and
older, among whom non-psychiatric use is more common (Sihvo et al., 2008;
Thielen  et  al.,  2009).  Additional  analyses  conducted  for  sub-study  II
comparing registered antidepressant purchases to Finnish population-based
survey data with clinical assessment of depression (Sihvo et al., 2008) revealed
that 64 per cent of middle-aged Finns making non-tricyclic antidepressant
purchases had either current major depression or a self-reported history of
doctor-diagnosed depression. Thus, although not perfect, non-tricyclic
antidepressant purchases could be considered a reasonable proxy for having
outpatient treatment for depression.
The use of  register data limited the analysis  of  depression outcomes and
treatment to those in contact with healthcare services, and social differentials
may  be  larger  in  the  general  population.  Relying  on  register  data  also
prevented  the  assessment  of  positive  outcomes  such  as  recovery  from
depression, given that the reasons for discontinuing antidepressants are not
known, for example. In particular, early discontinuation may well be related
to non-adherence and worse outcomes than early recovery (Melartin et al.,
2005).
7.2.3 FIXED-EFFECTS REGRESSION
When the causal connection between rising antidepressant sales and declining
suicide rates was evaluated, a region and time fixed-effects design was used to
control for all time-invariant regional characteristics and national time trends
that could influence the suicide risk irrespective of regional antidepressant
sales.  This  model  is  a  stronger test  of  causality  between two trends than an
ordinary  regression  model  controlling  for  observed  confounders  because  it
removes the confounding effects of all other co-occurring trends, both
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observed and unobserved (Allison, 2009). In practice this means that effects
are only inferred from the variation between regions in how antidepressant
sales and suicide risk changed over time, whereas the differences in levels
between regions and years are controlled for.
Some authors argue that controlling for time (i.e. removing all year-to-year
variation,  which  is  common  across  regions)  is  an  over-adjustment  and
prevents analysis of other predictors such as antidepressant sales (Gusmão et
al.,  2013).  The  model  cannot  identify  whether  the  year-to-year  variation
common to all regions, namely the decreasing national trend in suicide risk,
was, in fact, brought about by increased antidepressant sales. Thus if there was
little regional variation around the national trend, controlling for everything
that is  common across regions could mask the beneficial  effect  of  increased
sales.
Another limitation of fixed-effect models is the imprecision of estimates
due to reduced statistical  power compared with ordinary regression models
(Allison,  2009;  Kaufman,  2008;  Madsen  and  Osler,  2009).  It  is  therefore
difficult to draw a firm conclusion that antidepressants do not have a beneficial
effect, even with this large sample of almost one million individuals and 11,491
suicides.  This  is  particularly  true  for  alcohol-related  and  female  suicides,
which  are  less  common  than  non-alcohol-related  male  suicides.  These
limitations could be overcome by combining individual-level data from other
Nordic countries with comparable registers. Such data would provide more
statistical power and likely more variation in regional trends of antidepressant
sales and suicide mortality for detecting or rejecting the beneficial effect of
increased  antidepressant  sales  on  less  common  events  such  as  female  and
alcohol-related suicide.
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8 CONCLUSIONS
This study examined social differentials in depression outcomes and
antidepressant treatment, using large longitudinal sets of register data that are
representative of the general adult population of Finland. The findings
strengthen the existing evidence from mainly small samples that the risk for
psychiatric  hospital  care  and  the  excess  mortality  of  depression  vary  only
moderately according to social factors such as socioeconomic position and
living arrangements. However, through the simultaneous assessment of
various aspects of socioeconomic position the results revealed the relative
importance of  material  factors such as low income, not owning a home and
unemployment  in  increasing  the  risk  for  an  adverse  course  of  depression,
whereas  education  and  occupational  social  class  had  little  to  no  effect.
Although confounding by depression severity and reverse causality cannot be
ruled  out,  these  results  imply  that  financial  strain  is  a  major  obstacle  to
managing  with  and  recovering  from  depression.  Given  that  depression  is  a
common cause of work disability (Gould et al., 2007) and thus of a reduction
in income, this poses a challenge for the adequacy of social-security benefits
such as disability pensions in preventing the adverse outcomes of depression.
The study produced new information about the contribution of alcohol-
related deaths to depression mortality. About half of the excess deaths among
depressed  men,  and  around  a  third  among  depressed  women,  were
attributable to alcohol, mostly involving alcohol diseases, particularly among
depressed outpatients. All in all, alcohol-related causes, suicides and other
violent and accidental causes of death accounted for around 70 per cent of the
excess mortality among depressed men, and 55–70 per cent among depressed
women, emphasising the importance of behavioural pathways in bringing
about the higher mortality among the depressed. Targeting hazardous health
behaviours,  alcohol  abuse  in  particular,  should  thus  be  a  priority  in  the
prevention of depression-related mortality.
The results did not support the claim of unequal access to antidepressant
treatment at a time of evident need, namely immediately before and after
hospital care for depression: educational differences in any antidepressant use
during these periods were small. However, the prevalence of antidepressant
use  declined  more  rapidly  after  hospital  discharge  among  the  less  highly
educated, suggesting less treatment adherence in this group. Furthermore, the
daily  use  of  antidepressants  was  less  common  among  those  with  a  low
educational level, and educational differences were more pronounced than for
any antidepressant use. Improving adherence among the low educated group
thus seems to be the key challenge for reducing social differentials in
antidepressant treatment, at least among depressed patients already in
contact with the healthcare system. Social differentials in contacting
healthcare services in the first place, as well as differentials in access to non-
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pharmacological treatments such as psychotherapy, may also contribute to the
unequal provision of depression treatment, and require further investigation.
Improved antidepressant adherence, reflected in the increasing proportion
of antidepressant users with minimally adequate treatment, may have
accounted for over half of the decrease in non-alcohol-related male suicides in
Finland  in  1995–2007.  On  the  other  hand,  the  study  failed  to  show  any
beneficial effect of increased antidepressant sales on alcohol-related or female
suicides. Apart from methodological reasons that may hinder the detection of
an effect in these less common types of suicide, the lack of effect may relate to
the targeting of antidepressant treatment. In particular, depression treatment
has been found inadequate among patients at high risk for alcohol-related
suicide,  namely those with comorbid substance use disorders (Blanco et  al.,
2012;  Suominen  et  al.,  2002),  and  thus  increased  antidepressant  treatment
may not have benefitted this group equally.
Overall, the results of the study highlight the need to improve the detection
and  appropriate  management  of  comorbid  substance  use  disorders  in
depression. A better understanding of the role of alcohol in depression is vital
in the planning of integrated mental healthcare and social services as well as
in designing preventive strategies with regard to depression and suicide.
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